Compounds having a spirobifluorene structure

Spirobifluorene derivatives substituted with pyridine and/or pyrimidine groups address the inefficiencies in organic electroluminescent devices by providing improved matrix materials that enhance efficiency, lifetime, and reduce operating voltage, while maintaining solubility and processability.

JP7587540B2Active Publication Date: 2024-11-20MERCK PATENT GMBH
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
JP2022014430
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2016-03-17
Filing Date
2022-02-01
Publication Date
2024-11-20
Estimated Expiration
2037-03-15

AI Technical Summary

Technical Problem

Existing organic electroluminescent devices, particularly phosphorescent OLEDs, face challenges in achieving high efficiency, long lifetime, and low operating voltage, with a need for improved matrix materials that also exhibit good solubility and film-forming properties.

Method used

Development of spirobifluorene derivatives substituted with pyridine and/or pyrimidine groups, which serve as matrix materials in organic electroluminescent devices, offering enhanced performance in terms of efficiency, lifetime, and operating voltage, while maintaining oxidative stability and processability.

Benefits of technology

The spirobifluorene derivatives provide organic electroluminescent devices with improved efficiency, extended lifetime, and reduced operating voltage, while ensuring good solubility and film-forming properties, thereby enhancing the overall performance of electronic components.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007587540000001
    Figure 0007587540000001
  • Figure 0007587540000002
    Figure 0007587540000002
  • Figure 0007587540000003
    Figure 0007587540000003
Patent Text Reader

Abstract

Spirobifluorene derivatives substituted with pyridine and / or pyrimidine groups are provided, particularly for use in electronic devices. The present invention relates to a compound represented by formula (I). JPEG2022078024000077.jpg46143 X may be the same or different at each occurrence and may be N or CR 1 with the proviso that not more than two of the X groups in one ring are N, or C is L 1 Q is, in each case, one or more R 1 a pyrimidine or pyridine group optionally substituted with a radical; L 1 has 5 to 24 aromatic or heteroaromatic ring atoms and one or more R 1 It is an aromatic or heteroaromatic ring system which may be substituted with radicals.
Need to check novelty before this filing date? Find Prior Art

Description

Detailed Description of the Invention

[0001] The present invention describes spirobifluorene derivatives substituted with pyridine and / or pyrimidine groups, in particular for use in electronic devices. The present invention further relates to a process for the preparation of the compounds of the invention and to electronic devices comprising these compounds.

[0002] The structures of organic electroluminescent devices (OLEDs), in which organic semiconductors are used as functional materials, are described, for example, in US4539507, US5151629, EP0676461 and WO98 / 27136. The emitting materials used are often phosphorescent organometallic complexes. For quantum mechanical reasons, the use of organometallic compounds as phosphorescent emitters allows for up to four times the energy and power efficiency. There is still a need for improvements in OLEDs in general, and in phosphorescent OLEDs in particular, for example with regard to efficiency, operating voltage and lifetime.

[0003] The properties of organic electroluminescent devices are not only determined by the emitter used. Here, other materials used are particularly important, such as host and matrix materials, electron transport materials, hole transport materials, and electron or exciton blocking materials. Improvements to these materials can bring about clear improvements in electroluminescent devices.

[0004] Heteroaromatic compounds, such as triazine derivatives or benzimidazole derivatives, are often used according to the prior art as matrix materials for phosphorescent compounds and as electron transport materials.Derivatives known for this function are, for example, spirobifluorene derivatives substituted with triazine groups at 2-position, as disclosed in WO2010 / 015306 and WO2010 / 072300.However, pyrimidine radicals are directly bonded to the spirobifluorene group.Furthermore, EP2468731 discloses heterocyclic compounds with fluorene structure.Similar compounds are further known from WO2013 / 191429 and EP2108689.

[0005] In general, in the case of these materials, which are used, for example, as matrix materials, there is still a need for improvements in the devices, especially with regard to their lifetime, but also with regard to their efficiency and operating voltage.

[0006] The problem addressed by the present invention is therefore to provide compounds which are suitable for use in organic electronic devices, in particular organic electroluminescent devices, and which when used in such devices result in good device properties, and to provide corresponding electronic devices.

[0007] More specifically, the problem addressed in the present invention is to provide compounds that provide long lifetime, good efficiency and low operating voltage. In particular, the properties of the matrix material also have a substantial impact on the lifetime and efficiency of an organic electroluminescent device.

[0008] A further problem addressed by the present invention is believed to be the provision of compounds suitable, in particular as matrix materials, in phosphorescent or fluorescent OLEDs. It is a particular object of the present invention to provide matrix materials suitable for red, yellow and green phosphorescent OLEDs, and possibly also for blue phosphorescent OLEDs.

[0009] Furthermore, the compounds must be processable in a very simple manner and must in particular exhibit good solubility and film-forming properties, for example they must exhibit oxidative stability on heating and improved glass transition temperatures.

[0010] A further object is to provide electronic components with excellent performance at very low cost and with consistent quality.

[0011] Also, the electronic device must be capable of being used or adapted for many purposes, and more particularly, the performance of the electronic device must be maintained over a wide temperature range.

[0012] Surprisingly, it has been found that a specific compound, which will be disclosed in detail hereinafter, solves these problems and reduces the disadvantages of the prior art.The use of this compound leads organic electronic devices, particularly organic electroluminescent devices, to very good properties, particularly in terms of lifetime, efficiency and operating voltage.Therefore, the electronic device, particularly organic electroluminescent device, comprising such compound and corresponding preferred forms is provided by the present invention.

[0013] Accordingly, the present invention provides a compound of formula (I): [ka] where the symbols used are as follows: X is the same or different for each occurrence and is N or CR 1 , preferably CR 1 , and Q is, in each case, 1 or more R 1 a pyrimidine or pyridine group, optionally substituted with a radical; L 1 has 5 to 24 aromatic or heteroaromatic ring atoms and one or more R 1an aromatic or heteroaromatic ring system, optionally substituted with a radical, having 5 to 24 aromatic ring atoms, the aromatic or heteroaromatic ring system containing up to 2 nitrogen atoms; R 1 are the same or different for each occurrence and are H, D, F, Cl, Br, I, CN, Si(R 2 ) 3, a linear alkyl, alkoxy, or thioalkoxy group having 1 to 40 carbon atoms, or a branched or cyclic alkoxy or thioalkoxy group having 3 to 40 carbon atoms, each of which may be one or more R 2 radicals, where in each case one or more non-adjacent CH groups are replaced by -R 2 C=CR 2 -, -C≡C-, Si(R 2 )2, C=O, C=S, C=NR 2 , -C(=O)O-, -C(=O)NR 2 -, NR 2 , P(=O)(R 2 ), -O-, -S-, SO, or SO2, and one or more hydrogen atoms may be replaced by D, F, Cl, Br, I, CN, or NO2), or having 5 to 40 aromatic ring atoms, and in each case, one or more R 2 Aromatic or heteroaromatic ring systems, optionally substituted by radicals, having 5 to 60 aromatic ring atoms and one or more R 2 an aryloxy or heteroaryloxy group, optionally substituted with a radical, or having 5 to 60 aromatic ring atoms, and in each case one or more R 2 an aralkyl group, optionally substituted with a radical, or a combination of these systems, where optionally two or more adjacent R 1 The substituents are monocyclic or polycyclic, and one or more R 2 may form an aliphatic or aromatic ring system which may be substituted with radicals; R 2 are the same or different for each occurrence and are H, D, F, Cl, Br, I, CN, Si(R2 ) 3, a linear alkyl, alkoxy, or thioalkoxy group having 1 to 40 carbon atoms, or a branched or cyclic alkoxy or thioalkoxy group having 3 to 40 carbon atoms, each of which may be one or more R 3 radical, where one or more non-adjacent CH groups are -R 3 C=CR 3 -, -C≡C-, Si(R 3 )2, C=O, C=S, C=NR 3 , -C(=O)O-, -C(=O)NR 3 -, NR 3 , P(=O)(R 3 ), -O-, -S-, SO, or SO2, and one or more hydrogen atoms may be replaced by D, F, Cl, Br, I, CN, or NO2), or having 5 to 40 aromatic ring atoms, and in each case having one or more R 3 Aromatic or heteroaromatic ring systems, optionally substituted with radicals, having 5 to 60 aromatic ring atoms and one or more R 3 an aryloxy or heteroaryloxy group, optionally substituted by a radical, or a aryloxy group having 5 to 60 aromatic ring atoms and in each case one or more R 2 an aralkyl group, optionally substituted with a radical, or a combination of these systems, where optionally two or more adjacent R 2 The substituents are monocyclic or polycyclic, and one or more R 3 may form an aliphatic or aromatic ring system, optionally substituted with radicals,

[0014] In the context of the present invention, adjacent carbon atoms are carbon atoms that are directly bonded to each other. Furthermore, in the definition of radicals, "adjacent radicals" means that these radicals are bonded to the same carbon atom or adjacent carbon atoms. These definitions apply in particular to the terms "adjacent groups" and "adjacent substituents".

[0015] The expression that two or more radicals may form a ring with each other is understood in the context of the present invention to mean, in particular, that the two radicals are linked to each other by a chemical bond under the formal removal of two hydrogen atoms. This is illustrated by the following scheme: [ka]

[0016] Furthermore, however, the above expression is also understood to mean that if one of the two radicals is hydrogen, the second radical is bonded to the bonded position of the hydrogen atom to form a ring, which is illustrated by the following scheme: [ka]

[0017] In the context of the present invention, fused aryl group, fused aromatic ring system, or compound heteroaromatic ring system is a group in which two or more aromatic groups are fused to each other through one common side, i.e., fused rings, for example, two carbon atoms belong to at least two aromatic or heteroaromatic rings, such as in naphthalene.In contrast, for example, fluorene is not a fused aryl group in the context of the present invention, since the two aromatic groups in fluorene do not have a common side.The corresponding definition applies to heteroaryl groups and fused ring systems (which may, but do not have to, contain heteroatoms).

[0018] In the context of the present invention, an aryl group contains 6 to 40 carbon atoms; in the context of the present invention, a heteroaryl group contains 2 to 40 carbon atoms and at least one heteroatom, with the proviso that the sum of carbon atoms and heteroatoms is at least 5. The heteroatoms are preferably selected from N, O and / or S. An aryl or heteroaryl group is understood here to mean a single aromatic ring, i.e. benzene, or a single heteroaromatic ring, such as pyridine, pyrimidine, thiophene, etc., or fused, aryl or heteroaryl groups, such as naphthalene, anthracene, phenanthrene, quinoline, isoquinoline, etc.

[0019] In the context of the present invention, an aromatic ring system has 6 to 40 carbon atoms in the ring system. In the context of the present invention, a heteroaromatic ring system contains 1 to 40 carbon atoms and at least one heteroatom in the ring system, provided that the sum of carbon atoms and heteroatoms is at least 5. The heteroatom is preferably selected from N, O and / or S. In the context of the present invention, an aromatic or heteroaromatic ring system should be understood to mean a system that does not necessarily contain only aryl or heteroaryl groups, but in which two or more aryl or heteroaryl groups can also be interrupted by non-aromatic units (preferably less than 10% of atoms other than H), such as carbon, nitrogen or oxygen atoms or carbonyl groups. For example, systems such as 9,9'-spirobifluorene, 9,9-diarylfluorene, triarylamines, diaryl ethers, stilbenes, etc., are also considered as aromatic ring systems in the context of the present invention, as are systems in which two or more aryl groups are interrupted, for example, by linear or cyclic, alkyl groups or by silyl groups. Additionally, systems in which two or more aryl or heteroaryl groups are directly bonded to each other, such as biphenyl, terphenyl, quaterphenyl, or bipyridine, are also considered aromatic or heteroaromatic ring systems.

[0020] In the context of this invention a cyclic alkyl, alkoxy or thioalkoxy group is taken to mean a monocyclic, bicyclic or polycyclic group.

[0021] In the context of the present invention, C1-C alkoxy groups, in which individual hydrogen atoms or CH2 groups may be substituted by the above-mentioned groups, are also included. 20The alkyl group in the formula (I) is, for example, methyl, ethyl, n-propyl, i-propyl, cyclopropyl, n-butyl, i-butyl, s-butyl, t-butyl, cyclobutyl, 2-methylbutyl, n-pentyl, s-pentyl, t-pentyl, 2-pentyl, neopentyl, cyclopentyl, n-hexyl, s-hexyl, t-hexyl, 2-hexyl, 3-hexyl, neohexyl, cyclohexyl, 1-methylcyclopentyl, 2-methylpentyl, n-heptyl, 2-heptyl, 3-heptyl, 4-heptyl, cycloheptyl, 1-methylcyclohexyl, n-octyl, 2-ethylhexyl, cyclooctyl, 1-bicyclo[2.2.2]octyl, 2-bicyclo[2.2.2]octyl, 2-(2,6-dimethyl)octyl, 3-(3,7-dimethyl)octyl, adamantyl, trifluoromethyl, pentafluoroethyl, 2,2,2-trifluoroethyl, 1,1-dimethyl-n-hex-1-yl, 1,1-dimethyl-n-hepta- 1-yl, 1,1-dimethyl-n-oct-1-yl, 1,1-dimethyl-n-dec-1-yl, 1,1-dimethyl-n-dodec-1-yl, 1,1-dimethyl-n-tetradec-1-yl, 1,1-dimethyl-n-hexadece-1-yl, 1,1-dimethyl-n-octadec-1-yl, 1,1-diethyl-n-hex-1-yl, 1,1-diethyl-n-hept-1-yl, 1,1-diethyl-n-oct-1-yl, 1,1-diethyl-n-dec-1-yl, 1, It is understood to mean 1-diethyl-n-dodec-1-yl, 1,1-diethyl-n-tetradec-1-yl, 1,1-diethyl-n-hexadece-1-yl, 1,1-diethyl-n-octadec-1-yl, 1-(n-propyl)cyclohex-1-yl, 1-(n-butyl)cyclohex-1-yl, 1-(n-hexyl)cyclohex-1-yl, 1-(n-octyl)cyclohex-1-yl and 1-(n-decyl)cyclohex-1-yl radicals. Alkenyl groups are understood to mean, for example, ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl, cyclooctenyl or cyclooctadienyl.An alkynyl group is understood to mean, for example, ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl or octynyl. C1-C. 40 An alkoxy group is taken to mean, for example, methoxy, trifluoromethoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, i-butoxy, s-butoxy, t-butoxy or 2-methylbutoxy.

[0022] Aromatic or heteroaromatic ring systems, which have 5 to 40 aromatic ring atoms, which in each case may be substituted by the abovementioned radicals and which may be bonded to the aromatic or heteroaromatic system in any desired position, are understood to mean, for example, radicals derived from: benzene, naphthalene, anthracene, benzanthracene, phenanthrene, benzophenanthrene, pyrene, chrysene, perylene, fluoranthene, benzofluoranthene, naphthacene, pentacene, benzopyrene, biphenyl, biphenylene, terphenylene, fluorene, terphenylene, fluorene, spirobifluorene, dihydrophenanthrene, dihydropyrene, tetrahydropyrene, cis- or trans-indenofluorene, cis- or trans-monobenzoindenofluorene, cis- or trans-dibenzoindenofluorene, truxene, isotruxene, spirotruxene, spiroisotruxene, furan, benzofuran, isobenzofuran, dibenzofuran, thiophene, benzothiophene, isobenzothiophene, dibenzothiophene, pyrrole, indole, isoindole, Carbazole, indolocarbazole, indenocarbazole, pyridine, quinoline, isoquinoline, acridine, phenanthridine, benzo-5,6-quinoline, benzo-6,7-quinoline, benzo-7,8-quinoline, phenothiazine, phenoxazine, pyrazole, indazole, imidazole, benzimidazole, naphthimidazole, phenanthrimidazole, pyridimidazole, pyrazinimidazole, quinoxalinimidazole, oxazole, benzoxazole, naphthoxazole, anthroxazole, phenanthroxazole, Isoxazole, 1,2-thiazole, 1,3-thiazole, benzothiazole, pyridazine, benzopyridazine, pyrimidine, benzopyrimidine, quinoxaline, 1,5-diazaanthracene, 2,7-diazapyrene, 2,3-diazapyrene, 1,6-diazapyrene, 1,8-diazapyrene, 4,5-diazapyrene, 4,5,9,10-tetraazapyrylene, pyrazine, phenazine, phenoxazine, phenothiazine, fluorubine, naphthyridine, azacarbazole, benzocarboline, phenanthroline, 1,2,3-triazole, 1,2,4-triazole, benzotriazole, 1,2,3-oxadiazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole, 1,3,4-oxadiazole, 1,2,3-thiadiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole, 1,3,4-thiadiazole, 1,3,5-triazine, 1,2,4-triazine, 1,2,3-triazine, tetrazole, 1,2,4,5-tetrazine, 1,2,3,4-tetrazine, 1,2,3,5-tetrazine, purine, pteridine, indolizine, and benzothiadiazole.

[0023] In a preferred configuration, the compounds of the invention may form the structure of formula (Ia), (Ib), (Ic) and / or (Id). [ka] In the formula, symbols X and L 1 and Q have the meanings given above, in particular in formula (I). In this context, preference is given to compounds having the structure of formula (Ia), (Ib) and / or (Ic), particularly preference to compounds having the structure of formula (Ia).

[0024] Preferably, the compounds of the present invention may comprise a structure of formula (II), preferably formula (IIa), (IIb), (IIc) and / or (IId). [ka] [ka] In the formula, symbols X and L 1 and Q have the meanings given above, in particular in formula (I). In this context, preference is given to compounds having the structure of formula (IIa), (IIb) and / or (IIc), particularly preference to compounds having the structure of formula (IIa).

[0025] Also, in formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc) and / or (IId), not more than two of the X groups are N, preferably not more than one of the X groups is N, and preferably all X are CR 1 where X denotes the CR 1 Preference is given to compounds characterized in that of the groups, preferably at most 4, more preferably at most 3 and particularly preferably at most 2 are not CH groups.

[0026] Furthermore, in formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc) and / or (IId), R of the X group 1 This may be the case where the radical does not form a fused aromatic or heteroaromatic ring system with the ring atoms of the spirobifluorene structure, preferably does not form any fused ring system. 1 Any R that may be attached to a radical 2 , R 3 In formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc) and / or (IId), R of the X group includes the formation of a fused ring system with the substituent. 1 It is preferred that the radicals do not form any ring system with the ring atoms of the spirobifluorene structure. 1 Any R that may be attached to a radical 2 , R 3 The formation of a ring system with the substituents is included.

[0027] Preferably, the compound of the present invention may comprise the structure of formula (III), preferably formula (IIIa), (IIIb), (IIIc) and / or (IIId) (Ia), (IIa), (IIIa) and / or (IVa). [ka] In the formula, the symbol R 1 , L 1and Q have the meanings given above, in particular in formula (I), m is 0, 1, 2, 3 or 4, preferably 0, 1 or 2, and n is 0, 1, 2 or 3, preferably 0, 1 or 2. In this context, preference is given to compounds having the structure of formula (IIIa), (IIIb) and / or (IIIc), particularly preferred are compounds having the structure of formula (IIIa).

[0028] Preferably, the compound of the present invention may comprise the structure of formula (IV), preferably formula (IVa), (IVb), (IVc) and / or (IVd). [ka] [ka] In the formula, the symbol R 1 , L 1 and Q have the meanings given above, in particular in formula (I), m is 0, 1, 2, 3 or 4, preferably 0, 1 or 2, and n is 0, 1, 2 or 3, preferably 0, 1 or 2. In this context, preference is given to compounds having the structure of formula (IVa), (IVb) and / or (IVc), particularly preference is given to compounds having the structure of formula (IVa).

[0029] Compounds of formulae (Ic), (IIc), (IIIc) and (IVc) are particularly preferred herein.

[0030] Furthermore, in the formula (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd), R 1 This may be the case where the substituents do not form a fused aromatic or heteroaromatic ring system with the ring atoms of the spirobifluorene structure, preferably do not form any fused ring system. 1 Any R that may be attached to a radical 2 , R 3In formula (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd), R of the spirobifluorene structure includes the formation of a fused ring system with the substituent. 1 It is preferred that the substituents do not form a ring system with the ring atoms of the spirobifluorene structure. 1 Any R that may be attached to a radical 2 , R 3 The formation of a ring system with the substituents is included.

[0031] Furthermore, in the structures of formula (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd), the sum of the indices m and 2 may in each case be 3 or less, preferably 2 or less, more preferably 1 or less.

[0032] In a preferred structure, the compound comprising the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) can be represented by the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd). Preferably, the compounds comprising the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) have a molecular weight of less than or equal to 5000 g / mol, preferably less than or equal to 4000 g / mol, particularly preferably less than or equal to 3000 g / mol, especially preferably less than or equal to 2000 g / mol and most preferably less than or equal to 1200 g / mol.

[0033] A further feature of the preferred compounds of the invention is that they are sublimable. These compounds generally have a molar mass of less than about 1200 g / mol.

[0034] The Q group, in each case, is one or more R 1 A pyrimidine or pyridine group, optionally substituted by a radical. A pyrimidine or pyridine group comprises at least one heteroaromatic ring having 6 ring atoms and 1 or 2 nitrogen atoms. A triazine group is not a pyrimidine or pyridine group, since it comprises 3 nitrogen atoms in the heteroaromatic ring.

[0035] Preferably, the Q group shown in formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) may be selected from the structures of formula (Q-1), (Q-2), (Q-3) and / or (Q-4). [ka] In the formula, the symbols X and R 1 has the meaning given above, especially in formula (I), and the dotted line indicates the point of attachment, where X is preferably a nitrogen atom.

[0036] Preferably, the Q group as shown in formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd), among others, may be selected from structures of formula (Q-5), (Q-6), (Q-7), (Q-8), (Q-9) and / or (Q-10). [ka] In the formula, the symbol R1 has the meaning described above, especially in formula (I), the dotted line indicates the connection point and m is 0, 1, 2, 3 or 4, preferably 0, 1 or 2, and n is 0, 1, 2 or 3, preferably 0, 1 or 2, preferably structures of formulae (Q-8), (Q-9) and (Q-10).

[0037] In a further aspect, the Q group as depicted in formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) may be selected from structures of formula (Q-11), (Q-12), (Q-13) and / or (Q-14). [ka] In the formula, the symbol R 1 has the meaning given above, especially in formula (I), and the dotted line indicates the connection point, preferably structures of formulae (Q-13) and (Q-14).

[0038] Preferably, R is as shown in particular in the structures of formulae (Q-1), (Q-2), (Q-4), (Q-5), (Q-6), (Q-7), (Q-8), (Q-9), (Q-10), (Q-11), (Q-12), (Q-13) and / or (Q-14), optionally linked to a pyridine or pyrimidine group. 1 The radical is a compound characterized in that it does not form an aromatic or heteroaromatic ring system with the ring atoms of the pyridine or pyrimidine group, preferably does not form any fused rings. 1 Any R that may be attached to a radical 2 , R 3 Ring formation with the substituents is also included.

[0039] In a further embodiment, R is optionally linked to a pyridine or pyrimidine group, as shown in the structures of the formulae (Q-1), (Q-2), (Q-4), (Q-5), (Q-6), (Q-7), (Q-8), (Q-9), (Q-10), (Q-11), (Q-12), (Q-13) and / or (Q-14), among others. 1 This may also be the case where the radical has up to two nitrogen atoms, preferably up to one nitrogen atom, particularly preferably up to two heteroatoms, more preferably no heteroatoms.

[0040] X is CR 1 or the aromatic and / or heteroaromatic groups are R 1 When substituted by a substituent, these R 1 The substituents are preferably H, D, F, CN, N(Ar 1 )2, C(=O)Ar 1 , P(=O)(Ar 1 ) 2, a linear alkyl or alkoxy group having 1 to 10 carbon atoms, or a branched or cyclic alkyl or alkoxy group having 3 to 10 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms (each of which may be represented by one or more R 2 radicals, where one or more non-adjacent CH groups are optionally replaced by O and where one or more hydrogen atoms are optionally replaced by D or F); aromatic or heteroaromatic ring systems having 5 to 24 aromatic ring atoms (each of which may be substituted by one or more R 2 radicals, but preferably unsubstituted), or having 5 to 25 aromatic ring atoms and one or more R 2 aryl or heteroaryl groups, optionally substituted by an aryl or heteroaryl group; 1 The substituents may be one or more monocyclic or polycyclic R 1 may form an aliphatic, aromatic or heteroaromatic ring system, optionally substituted by radicals, where Ar 1are identical or different at each occurrence, have 6 to 40 carbon atoms, and in each case, one or more R 2 Aromatic or heteroaromatic ring systems, optionally substituted by radicals, having 5 to 60 aromatic ring atoms and one or more R 2 an aryloxy group, optionally substituted by a radical, or an aromatic ring having 5 to 60 aromatic ring atoms, in each case one or more R 2 an aralkyl group, optionally substituted by a radical, where adjacent R 2 The substituents may optionally form a monocyclic or polycyclic aliphatic ring system, where the symbol R 2 has the meaning given above, in particular in formula (I). 1 are identical or different at each occurrence and have 5 to 24, preferably 5 to 12, aromatic ring atoms, and in each case one or more R 2 The radical is an optionally substituted, but preferably unsubstituted, aryl or heteroaryl group.

[0041] Appropriate Ar 1 Exemplary groups are selected from the group consisting of phenyl, ortho-, meta- or para-biphenyl, terphenyl, especially branched terphenyl, quaternary phenyl, especially branched quaternary phenyl, 1-, 2-, 3- or 4-fluorenyl, 1-, 2-, 3- or 4-spirobifluorenyl, pyridyl, pyrimidinyl, 1-, 2-, 3- or 4-dibenzofuranyl, 1-, 2-, 3- or 4-dibenzothienyl and 1-, 2-, 3- or 4-carbazolyl, each of which may be selected from the group consisting of one or more R 2 The radicals may be substituted, but are preferably unsubstituted.

[0042] More preferably, these R 1 The substituents are H, D, F, CN, N(Ar 1) 2, a straight-chain alkyl group having 1 to 8 carbon atoms, preferably having 1, 2, 3 or 4 carbon atoms, or a branched or cyclic alkyl group having 3 to 8 carbon atoms, preferably having 3 or 4 carbon atoms, or an alkenyl group having 2 to 8 carbon atoms, preferably having 2, 3 or 4 carbon atoms (each of which may be selected from the group consisting of one or more R 2 an aromatic or heteroaromatic ring system (each of which may be substituted by one or more R radicals, but is preferably unsubstituted) having 6 to 24 aromatic ring atoms, preferably having 6 to 18 aromatic ring atoms, and more preferably having 6 to 13 aromatic ring atoms; 2 radicals, but preferably unsubstituted; and at the same time, optionally, two R 1 The substituents may be one or more R 2 may form a monocyclic or polycyclic aromatic ring system, which may be substituted, but is preferably unsubstituted, by radicals, where Ar 1 may have the meaning given above.

[0043] Most preferably, R 1 The substituents are H and an aromatic or heteroaromatic ring system having 6 to 18 aromatic ring atoms, preferably having 6 to 13 aromatic ring atoms (each of which may be one or more R 2 The suitable R 1 Examples of substituents are selected from the group consisting of phenyl, ortho-, meta- or para-biphenyl, terphenyl, especially branched terphenyl, quaternary phenyl, especially branched quaternary phenyl, 1-, 2-, 3- or 4-fluorenyl, 1-, 2-, 3- or 4-spirobifluorenyl, pyridyl, pyrimidinyl, 1-, 2-, 3- or 4-dibenzofuranyl, 1-, 2-, 3- or 4-dibenzothienyl, 1-, 2-, 3- or 4-carbazolyl, each of which may be selected from the group consisting of one or more R 2The radicals may be substituted, but are preferably unsubstituted.

[0044] Furthermore, in the structures of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd), at least one R 1 The radical has the formula (R 1 -1)~(R 1 -80). [ka] [ka] [ka] [ka] [ka] [ka] where the symbols used are as follows: Y is O, S or NR 2 , preferably O or S; i, independently at each occurrence, is 0, 1, or 2; j is independently at each occurrence 0, 1, 2 or 3; h is, independently at each occurrence, 0, 1, 2, 3, or 4; g, independently at each occurrence, is 0, 1, 2, 3, 4, or 5; R 2 may have the meaning given above, in particular in formula (I), and The dotted lines indicate the connection locations.

[0045] Preferably, the formula (R 1-1)~(R 1 -80) such that the sum of the indices i, j, h and g in the structure is in each case 3 or less, preferably 2 or less, and more preferably 1 or less.

[0046] Preferably, the formula (R 1 -1)~(R 1 -80) R 2 The radical is R 2 The radical does not form an aromatic or heteroaromatic ring system with the ring atoms of the aryl or heteroaryl group to which it is attached, and preferably does not form any fused ring system. 2 Any R to which a radical may be attached 3 The formation of fused ring systems with the substituents is also included.

[0047] Preferably, L 1 The group may be selected from the group Q and L of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd). 1 The spirobifluorene group can form a through-conjugation with the aromatic or heteroaromatic radical to which it is attached. As soon as a direct bond is formed between adjacent aromatic or heteroaromatic rings, a direct conjugation of the aromatic or heteroaromatic system is formed. Further bonds between the above-mentioned conjugated groups, for example via sulfur, nitrogen or oxygen atoms or carbonyl groups, do not impair the conjugation. In the case of the fluorene system, two aromatic rings are directly bonded, where the 9-position SP 3 Although the -hybridized carbon atom prevents fusion of these rings, conjugation is possible, but this is due to the fact that the 9-SP 3-hybridized carbon atom is not necessarily located between the electron transporting Q group and the fluorene structure. In contrast, in the case of a spirobifluorene structure, direct conjugation can be formed if the bond between the Q group and the aromatic or heteroaromatic radical of the spirobifluorene group of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) is via the same phenyl group in the spirobifluorene structure or via phenyl groups in the spirobifluorene structure that are directly bonded to each other and are in the same plane. the bond between the Q group and the aromatic or heteroaromatic radical of the spirobifluorene group of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) is at position 9 of the spirobifluorene structure, i.e., 3 When the phenyl groups are bonded via different -hybridized carbon atoms, conjugation is prevented.

[0048] In a further preferred embodiment of the invention, L 1 is an aromatic or heteroaromatic ring system having 5 to 14 aromatic or heteroaromatic ring atoms, preferably an aromatic ring system having 6 to 12 carbon atoms, which is 1 It may be substituted by a radical, but is preferably unsubstituted, where R 1 may have the meanings given above, especially in formula (I). More preferably, L 1 is an aromatic ring system having 6 to 10 aromatic ring atoms, or a heteroaromatic ring system having 6 to 13 heteroaromatic ring atoms, each of which may be one or more R 2 It may be substituted by a radical, but is preferably unsubstituted, where R 2 may have the meaning given above, especially in formula (I).

[0049] More preferably, the symbol L, as shown in the structures of formulae (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd), among others, is 1 is identical or different on each occurrence and is an aryl or heteroaryl radical having 5 to 24 ring atoms, preferably 6 to 13 ring atoms, more preferably 6 to 10 ring atoms, the aromatic or heteroaromatic ring system of which is directly, i.e. via an atom of the aromatic or heteroaromatic group, bonded to the respective atom of the further group.

[0050] Furthermore, L, as shown in particular in the structures of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd), 1 This may be the case when the group comprises an aromatic ring system with no more than i2 fused aromatic and / or heteroaromatic rings, preferably no fused aromatic or heteroaromatic ring systems. Thus, naphthyl structures are preferred over anthracene structures. Furthermore, fluorenyl, spirobifluorenyl, dibenzofluorenyl and / or dibenzothienyl structures are preferred over naphthyl structures.

[0051] Particularly preferred are non-fused structures, such as phenyl, biphenyl, terphenyl and / or quaterphenyl structures.

[0052] A suitable aromatic or heteroaromatic ring system L 1Examples of are selected from the group consisting of ortho-, meta- or para-phenylene, ortho-, meta- or para-biphenylene, terphenylene, particularly branched terphenylene, quaterphenylene, particularly branched quaterphenylene, fluorenylene, spirobifluorenylene, dibenzofuranylene, dibenzothienylene, and carbazolylene, each of which may be selected from the group consisting of one or more R 2 The radicals may be substituted, but are preferably unsubstituted.

[0053] Furthermore, L, especially those having the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) 1 This may be the case where the group contains up to one nitrogen atom, preferably up to two heteroatoms, especially up to one heteroatom, and more preferably no heteroatoms.

[0054] Preferred are compounds comprising the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd), wherein L of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) 1 The group has the formula (L 1 -1)~(L 1 -108). [ka] [ka] [ka] [ka] [ka] [ka] [ka] where the dotted lines indicate in each case the point of attachment, the subscript k is 0 or 1, the subscript l is 0, 1 or 2, the subscript j is, independently at each occurrence, 0, 1, 2 or 3, the subscript h is, independently at each occurrence, 0, 1, 2, 3 or 4, the subscript g is 0, 1, 2, 3, 4 or 5, and the symbol Y is O, S or NR 2 , preferably O or S, and the symbol R 2 has the meaning given above, especially in formula (I).

[0055] Preferably, the formula (L 1 -1)~(L 1 -108), the sum of the subscripts k, l, g, h and j may in each case be at most 3, preferably at most 2, and more preferably at most 1.

[0056] Preferred compounds according to the invention have the formula (L 1 -1)~(L 1 -78) and / or (L 1 -92)~(L 1 -108), preferably of the formula (L 1 -1)~(L 1 -54) and / or (L 1 -92)~(L 1 -108), particularly preferably of the formula (L 1 -1)~(L 1 -29) and / or (L 1 -92)~(L 1 -103), 1 Advantageously, the compound of formula (L1 -1)~(L 1 -78) and / or (L 1 -92)~(L 1 -108), preferably of the formula (L 1 -1)~(L 1 -54) and / or (L 1 -92)~(L 1 -108), particularly preferably of the formula (L 1 -1)~(L 1 -29) and / or (L 1 -92)~(L 1 -103) the sum of the indices k, l, g, h and j in the structure is in each case 3 or less, preferably 2 or less, more preferably 1 or less.

[0057] More preferably, L 1 But the formula (L 1 -17)~(L 1 -108), more preferably the formula (L 1 -30)~(L 1 -108), even more preferably of the formula (L 1 -30)~(L 1 -52), (L 1 -55)~(L 1 -60), (L 1 -73)~(L 1 -91) and (L 1 -103)~(L 1 -108), particularly preferably of the formula (L 1 -30)~(L 1 -52) and (L 1 -103)~(L 1 -108).

[0058] Preferably, the formula (L 1 -1)~(L 1 -108) R 2 The radical is R 2 The radical does not form a fused aromatic or heteroaromatic ring system with the ring atoms of the aryl or heteroaryl group to which it is attached, and preferably does not form any fused ring system. 2 Any R that may be attached to a radical3 The formation of fused ring systems with the substituents is also included.

[0059] In addition, not more than one pyridine group may be present in L of the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd). 1 This may be the case when exactly one pyridine group is bonded to the L group of the structures of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd). 1 group, i.e. one or more pyrimidine groups and a further exactly one pyridine group may be linked to L 1 Preferably, the further pyridine group is attached to the L group of the structures of formulae (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) apart from the pyridine group and / or pyrimidine group. 1 is not bonded to the group.

[0060] Preferably, exactly one or less pyrimidine group is present in the L group of the structures of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd). 1In a particularly preferred embodiment, no pyridine group is attached and exactly one pyrimidine group is attached to the L group of the structures of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd).

[0061] In addition, not more than one nitrogen-containing heteroaromatic group may be present in L of the structures of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd). 1 This may be the case when, apart from just one pyridine or pyrimidine group, a further nitrogen-containing heteroaromatic group is bonded to the L 1 Preferably, not more than one nitrogen-containing heterocyclic group is bonded to the L group of the structures of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd). 1 is bonded to the group.

[0062] In addition, up to one heterocyclic group may be present in L of the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd). 1 This may be the case when a further heterocyclic group is attached to the L group apart from exactly one pyridine or pyrimidine group. 1 is meant to be bonded to a group.

[0063] Advantageously, it may be the case that the compounds of the invention comprising at least one structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) do not contain any carbazole and / or triarylamine groups. More preferably, the compounds of the invention do not contain any hole transport groups. Hole transport groups are known in the art and in many cases they are carbazole, indenocarbazole, indolocarbazole, arylamine or diarylamine structures.

[0064] In a further configuration, the compounds of the present invention comprising at least one of the structures of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) may comprise at least one hole transporting group, preferably a carbazole and / or a triarylamine group. Furthermore, the hole transporting group provided may be an indenocarbazole, indolocarbazole, arylamine or diarylamine group.

[0065] In a further preferred embodiment of the invention, R 2 is, for example, the same or different at each occurrence in the structures of formula (I) and preferred forms of these structures or structures related to these formulas, and is selected from the group consisting of H, D, an aliphatic hydrocarbon group having 1 to 10 carbon atoms, preferably 1, 2, 3 or 4 carbon atoms, or an aromatic or heteroaromatic ring system having 5 to 30 aromatic ring atoms, preferably 5 to 24 aromatic ring atoms, more preferably 5 to 13 aromatic ring atoms, each of which may be substituted with one or more alkyl groups, preferably unsubstituted, each of which has 1 to 4 carbon atoms.

[0066] In a further preferred embodiment of the invention, R 3 are, for example, identical or different at each occurrence in the structures of formula (I) and preferred forms of these structures or structures related to these formulas, and are selected from the group consisting of H, D, F, CN, an aliphatic hydrocarbon group having 1 to 10 carbon atoms, preferably 1, 2, 3 or 4 carbon atoms, or an aromatic or heteroaromatic ring system having 5 to 30 aromatic ring atoms, preferably having 5 to 24 aromatic ring atoms, more preferably having 5 to 13 aromatic ring atoms, each of which may be substituted with one or more alkyl groups, preferably unsubstituted, each of which has 1 to 4 carbon atoms.

[0067] The compounds of the present invention are aromatic or heteroaromatic R 1 or R 2 When substituted by groups, it is preferred that they do not have aryl or heteroaryl groups with more than two aromatic six-membered rings directly fused to each other. It is more preferred that the substituents do not have any aryl or heteroaryl groups with aromatic six-membered rings directly fused to each other. The reason for this preference is due to the low triplet energy of such structures. The fused aryl groups that have more than two aromatic six-membered rings directly fused to each other but are nevertheless suitable for the present invention are phenanthrene and triphenylene, because they also have high triplet levels.

[0068] Furthermore, it may be the case that the compound having the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) comprises up to one pyridine group. This means that the compound having the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) contains exactly one pyridine group or comprises one or more pyrimidine groups and further exactly one pyridine group. Preferably, the compounds having the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) do not contain further pyridine groups apart from the pyridine and / or pyrimidine groups.

[0069] Preferably, the compounds having the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) may comprise exactly one pyridine group. In a particularly preferred form, the compounds having the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) comprise no pyridine groups and exactly one pyrimidine group.

[0070] Furthermore, it may be the case that the compound having the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) comprises not more than one nitrogen-containing heteroaromatic group, which means that the compound does not contain further nitrogen-containing heteroaromatic groups apart from exactly one pyridine or pyrimidine group. Preferably, the compounds having the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) have not more than one nitrogen-containing heterocyclic group.

[0071] Furthermore, it may be the case that the compounds having the structure of formula (I), (Ia), (Ib), (Ic), (Id), (II), (IIa), (IIb), (IIc), (IId), (III), (IIIa), (IIIb), (IIIc), (IIId), (IV), (IVa), (IVb), (IVc) and / or (IVd) comprise not more than one heterocyclic group, which means that the compounds according to the invention preferably do not contain further heterocyclic groups apart from exactly one pyridine or pyrimidine group.

[0072] Particularly advantageously, compounds of formula (Ia), preferably (IIa), more preferably (IIIa) and especially preferred (IVa), in which L 1 The group has the formula (L 1 -93), and the Q group is selected from the structure of formula (Q-9), preferably (Q-14), and the Q group is selected from the structure of (R 1 -1)~(R 1 -80), preferably (R 1 -1), (R 1 -2), (R 1 -3), (R 1 -4), (R 1 -5), (R 1-6), (R 1 -7), (R 1 -8), (R 1 -9), (R 1 -10), (R 1 -11), (R 1 -12), (R 1 -13), (R 1 -14), (R 1 -15), (R 1 -16), (R 1 -17), (R 1 -18), (R 1 -19), (R 1 -20), (R 1 -21), (R 1 -22), (R 1 -23), (R 1 -24), (R 1 -25), (R 1 -26), (R 1 -27), (R 1 -28), (R 1 -29), (R 1 -30), (R 1 -31), (R 1 -32), (R 1 -33), (R 1 -34), (R 1 -35), (R 1 -36), (R 1 -37), (R 1 -38), (R 1 -39), (R 1 -40), (R 1 -41), (R 1 -42), (R 1 -43), (R 1 -44), (R 1 -45), (R 1 -46), (R 1 -47), (R 1 -48), (R 1 -49), (R 1 -50), (R 1 -51), two R 1 In this context, the formula (R 1 -1)~(R 1-80) each of the radicals R 2 groups, in particular R 2 group, and particularly preferably R 2 It has no group.

[0073] Particularly advantageously, compounds of formula (Ia), preferably (IIa), more preferably (IIIa) and especially preferred (IVa), in which L 1 The group has the formula (L 1 -93), and the Q group is selected from the structure of formula (Q-8), preferably (Q-13), and the Q group is selected from the structure of (R 1 -1), (R 1 -2), (R 1 -3), (R 1 -4), (R 1 -5), (R 1 -6), (R 1 -7), (R 1 -8), (R 1 -9), (R 1 -10), (R 1 -11), (R 1 -12), (R 1 -13), (R 1 -14), (R 1 -15), (R 1 -16), (R 1 -17), (R 1 -18), (R 1 -19), (R 1 -20), (R 1 -21), (R 1 -22), (R 1 -23), (R 1 -24), (R 1 -25), (R 1 -26), (R 1 -27), (R 1 -28), (R 1 -29), (R 1 -30), (R 1 -31), (R 1 -32), (R 1 -33), (R 1 -34), (R 1 -35), (R1 -36), (R 1 -37), (R 1 -38), (R 1 -39), (R 1 -40), (R 1 -41), (R 1 -42), (R 1 -43), (R 1 -44), (R 1 -45), (R 1 -46), (R 1 -47), (R 1 -48), (R 1 -49), (R 1 -50), (R 1 -51), two R 1 In this context, the formula (R 1 -1)~(R 1 -80) each of the radicals R 2 groups, in particular R 2 group, and particularly preferably R 2 It has no group.

[0074] Particularly advantageously, compounds of formula (Ia), preferably (IIa), more preferably (IIIa) and especially preferred (IVa), in which L 1 The group has the formula (L 1 -93), and the Q group is selected from the structure of formula (Q-10), preferably (Q-14), and the Q group is selected from the structure of (R 1 -1), (R 1 -2), (R 1 -3), (R 1 -4), (R 1 -5), (R 1 -6), (R 1 -7), (R 1 -8), (R 1 -9), (R 1 -10), (R 1 -11), (R 1 -12), (R 1 -13), (R 1 -14), (R 1 -15), (R1 -16), (R 1 -17), (R 1 -18), (R 1 -19), (R 1 -20), (R 1 -21), (R 1 -22), (R 1 -23), (R 1 -24), (R 1 -25), (R 1 -26), (R 1 -27), (R 1 -28), (R 1 -29), (R 1 -30), (R 1 -31), (R 1 -32), (R 1 -33), (R 1 -34), (R 1 -35), (R 1 -36), (R 1 -37), (R 1 -38), (R 1 -39), (R 1 -40), (R 1 -41), (R 1 -42), (R 1 -43), (R 1 -44), (R 1 -45), (R 1 -46), (R 1 -47), (R 1 -48), (R 1 -49), (R 1 -50), (R 1 -51), two R 1 In this context, the formula (R 1 -1)~(R 1 -80) each of the radicals R 2 groups, in particular R 2 group, and particularly preferably R 2 It has no group.

[0075] Particularly advantageously, compounds of formula (Ia), preferably (IIa), more preferably (IIIa) and especially preferred (IVa), in which L 1 The group has the formula (L 1 -92), and the Q group is selected from the structure of formula (Q-9), preferably (Q-14), and the Q group is selected from the structure of (R 1 -1), (R 1 -2), (R 1 -3), (R 1 -4), (R 1 -5), (R 1 -6), (R 1 -7), (R 1 -8), (R 1 -9), (R 1 -10), (R 1 -11), (R 1 -12), (R 1 -13), (R 1 -14), (R 1 -15), (R 1 -16), (R 1 -17), (R 1 -18), (R 1 -19), (R 1 -20), (R 1 -21), (R 1 -22), (R 1 -23), (R 1 -24), (R 1 -25), (R 1 -26), (R 1 -27), (R 1 -28), (R 1 -29), (R 1 -30), (R 1 -31), (R 1 -32), (R 1 -33), (R 1 -34), (R 1 -35), (R 1 -36), (R 1 -37), (R 1 -38), (R 1 -39), (R 1 -40), (R 1 -41), (R 1 -42), (R 1-43), (R 1 -44), (R 1 -45), (R 1 -46), (R 1 -47), (R 1 -48), (R 1 -49), (R 1 -50), (R 1 -51), two R 1 In this context, the formula (R 1 -1)~(R 1 -80) each of the radicals R 2 groups, in particular R 2 group, and particularly preferably R 2 It has no group.

[0076] Particularly advantageously, compounds of formula (Ia), preferably (IIa), more preferably (IIIa) and especially preferred (IVa), in which L 1 The group has the formula (L 1 -92), and the Q group is selected from the structure of formula (Q-8), preferably (Q-13), and the Q group is selected from the structure of (R 1 -1), (R 1 -2), (R 1 -3), (R 1 -4), (R 1 -5), (R 1 -6), (R 1 -7), (R 1 -8), (R 1 -9), (R 1 -10), (R 1 -11), (R 1 -12), (R 1 -13), (R 1 -14), (R 1 -15), (R 1 -16), (R 1 -17), (R 1 -18), (R 1 -19), (R 1 -20), (R 1 -21), (R 1 -22), (R 1-23), (R 1 -24), (R 1 -25), (R 1 -26), (R 1 -27), (R 1 -28), (R 1 -29), (R 1 -30), (R 1 -31), (R 1 -32), (R 1 -33), (R 1 -34), (R 1 -35), (R 1 -36), (R 1 -37), (R 1 -38), (R 1 -39), (R 1 -40), (R 1 -41), (R 1 -42), (R 1 -43), (R 1 -44), (R 1 -45), (R 1 -46), (R 1 -47), (R 1 -48), (R 1 -49), (R 1 -50), (R 1 -51), two R 1 In this context, the formula (R 1 -1)~(R 1 -80) each of the radicals R 2 groups, in particular R 2 group, and particularly preferably R 2 It has no group.

[0077] Particularly advantageously, compounds of formula (Ia), preferably (IIa), more preferably (IIIa) and especially preferred (IVa), in which L 1 The group has the formula (L 1 -92), and the Q group is selected from the structure of formula (Q-10), preferably (Q-14), and the Q group is selected from the structure of (R 1 -1), (R 1 -2), (R1 -3), (R 1 -4), (R 1 -5), (R 1 -6), (R 1 -7), (R 1 -8), (R 1 -9), (R 1 -10), (R 1 -11), (R 1 -12), (R 1 -13), (R 1 -14), (R 1 -15), (R 1 -16), (R 1 -17), (R 1 -18), (R 1 -19), (R 1 -20), (R 1 -21), (R 1 -22), (R 1 -23), (R 1 -24), (R 1 -25), (R 1 -26), (R 1 -27), (R 1 -28), (R 1 -29), (R 1 -30), (R 1 -31), (R 1 -32), (R 1 -33), (R 1 -34), (R 1 -35), (R 1 -36), (R 1 -37), (R 1 -38), (R 1 -39), (R 1 -40), (R 1 -41), (R 1 -42), (R 1 -43), (R 1 -44), (R 1 -45), (R 1 -46), (R 1 -47), (R 1 -48), (R 1 -49), (R 1 -50), (R 1 -51), two R 1In this context, the formula (R 1 -1)~(R 1 -80) each of the radicals R 2 groups, in particular R 2 group, and particularly preferably R 2 It has no group.

[0078] Particularly advantageously, compounds of formula (Ia), preferably (IIa), more preferably (IIIa) and especially preferred (IVa), in which L 1 The group has the formula (L 1 -94), and the Q group is selected from the structure of formula (Q-9), preferably (Q-14), and the Q group is selected from the structure of (R 1 -1), (R 1 -2), (R 1 -3), (R 1 -4), (R 1 -5), (R 1 -6), (R 1 -7), (R 1 -8), (R 1 -9), (R 1 -10), (R 1 -11), (R 1 -12), (R 1 -13), (R 1 -14), (R 1 -15), (R 1 -16), (R 1 -17), (R 1 -18), (R 1 -19), (R 1 -20), (R 1 -21), (R 1 -22), (R 1 -23), (R 1 -24), (R 1 -25), (R 1 -26), (R 1 -27), (R 1 -28), (R 1 -29), (R 1 -30), (R 1 -31), (R 1 -32), (R1 -33), (R 1 -34), (R 1 -35), (R 1 -36), (R 1 -37), (R 1 -38), (R 1 -39), (R 1 -40), (R 1 -41), (R 1 -42), (R 1 -43), (R 1 -44), (R 1 -45), (R 1 -46), (R 1 -47), (R 1 -48), (R 1 -49), (R 1 -50), (R 1 -51). Two R 1 In this context, the formula (R 1 -1)~(R 1 -80) each of the radicals R 2 groups, in particular R 2 group, and particularly preferably R 2 It has no group.

[0079] Particularly advantageously, compounds of formula (Ia), preferably (IIa), more preferably (IIIa) and especially preferred (IVa), in which L 1 The group has the formula (L 1 -94), and the Q group is selected from the structure of formula (Q-8), preferably (Q-13), and the Q group is selected from the structure of (R 1 -1), (R 1 -2), (R 1 -3), (R 1 -4), (R 1 -5), (R 1 -6), (R 1 -7), (R 1 -8), (R 1 -9), (R 1 -10), (R 1 -11), (R 1 -12), (R1 -13), (R 1 -14), (R 1 -15), (R 1 -16), (R 1 -17), (R 1 -18), (R 1 -19), (R 1 -20), (R 1 -21), (R 1 -22), (R 1 -23), (R 1 -24), (R 1 -25), (R 1 -26), (R 1 -27), (R 1 -28), (R 1 -29), (R 1 -30), (R 1 -31), (R 1 -32), (R 1 -33), (R 1 -34), (R 1 -35), (R 1 -36), (R 1 -37), (R 1 -38), (R 1 -39), (R 1 -40), (R 1 -41), (R 1 -42), (R 1 -43), (R 1 -44), (R 1 -45), (R 1 -46), (R 1 -47), (R 1 -48), (R 1 -49), (R 1 -50), (R 1 -51), two R 1 In this context, the formula (R 1 -1)~(R 1 -80) each of the radicals R 2 groups, in particular R 2 group, and particularly preferably R 2 It has no group.

[0080] Particularly advantageously, compounds of formula (Ia), preferably (IIa), more preferably (IIIa) and especially preferred (IVa), in which L 1 The group has the formula (L 1 -94), and the Q group is selected from the structure of formula (Q-10), preferably (Q-14), and the Q group is selected from the structure of (R 1 -1), (R 1 -2), (R 1 -3), (R 1 -4), (R 1 -5), (R 1 -6), (R 1 -7), (R 1 -8), (R 1 -9), (R 1 -10), (R 1 -11), (R 1 -12), (R 1 -13), (R 1 -14), (R 1 -15), (R 1 -16), (R 1 -17), (R 1 -18), (R 1 -19), (R 1 -20), (R 1 -21), (R 1 -22), (R 1 -23), (R 1 -24), (R 1 -25), (R 1 -26), (R 1 -27), (R 1 -28), (R 1 -29), (R 1 -30), (R 1 -31), (R 1 -32), (R 1 -33), (R 1 -34), (R 1 -35), (R 1 -36), (R 1 -37), (R 1 -38), (R 1 -39), (R 1 -40), (R 1 -41), (R 1 -42), (R1 -43), (R 1 -44), (R 1 -45), (R 1 -46), (R 1 -47), (R 1 -48), (R 1 -49), (R 1 -50), (R 1 -51). Two R 1 In this context, the formula (R 1 -1)~(R 1 -80) each of the radicals R 2 groups, in particular R 2 group, and particularly preferably R 2 It has no group.

[0081] Examples of suitable compounds of the present invention are the structures of the following formulas 1-57 shown below: [ka] [ka] [ka] [ka]

[0082] Preferred forms of the compounds of the invention are described in detail and specifically in the Examples, and these compounds can be used alone or in combination with further compounds for all purposes of the invention.

[0083] The preferred embodiments described above can be combined with one another if desired, provided that the conditions specified in claim 1 are met. In a particularly preferred embodiment of the invention, the preferred embodiments described above are applied simultaneously.

[0084] The compounds of the invention can in principle be prepared in a variety of ways, however the methods described below have been found to be particularly suitable.

[0085] Accordingly, the present invention further provides a method for preparing a compound comprising a structure of formula (I) by reacting a compound comprising at least one pyridine and / or pyrimidine group with a compound comprising at least one spirobifluorene radical in a coupling reaction.

[0086] Suitable compounds having pyridine and / or pyrimidine groups are often commercially available, whereby the starting compounds detailed in the examples can be obtained by known methods, as referenced therein.

[0087] These compounds can be reacted with further aryl compounds in known coupling reactions, the conditions necessary for this purpose are well known to those skilled in the art, and the detailed descriptions in the examples will assist those skilled in the art in carrying out these reactions.

[0088] Particularly suitable and preferred all coupling reactions leading to CC and / or CN bond formation are those due to Buchwald, Suzuki, Yamamoto, Stille, Heck, Negishi, Sonogashira and Hiyama. These reactions are well known and the examples provide further guidance to the skilled artisan.

[0089] In all of the synthetic schemes that follow, the compounds are shown with a small number of substituents to simplify the structures, and this does not preclude the presence of additional substituents as desired in the process.

[0090] Exemplary embodiments are shown in the following schemes, without these being intended to be limiting in any way: The constituent steps of the individual schemes can be combined with each other if desired. Scheme 1 [ka]

[0091] The methods shown for the synthesis of the compounds of the present invention should be considered as illustrative only: a person skilled in the art may develop alternative synthetic routes within the scope of his / her common knowledge in the art.

[0092] The basics of the preparation methods detailed above are in principle known from the literature for similar compounds and can be readily adapted by those skilled in the art to the preparation of the compounds of the invention. Further information can be found in the Examples.

[0093] By these methods, optionally followed by purification, such as recrystallization or sublimation, the compounds of the present invention comprising the structure of formula (I) can be obtained in high purity, preferably greater than 99% ( 1 H-NMR and / or HPLC).

[0094] The compounds of the invention may also have suitable substituents, such as relatively long alkyl groups (about 4 to 20 carbon atoms), especially branched alkyl groups, or optionally substituted aryl groups, such as xylyl, mesityl or branched terphenyl or quaterphenyl groups, which provide solubility in standard organic solvents, such as toluene or xylene, at room temperature and at sufficient solubility concentrations to allow the compounds to be processed in solution. These soluble compounds are particularly suitable for processing in solution, for example by printing methods. Moreover, it must be emphasized that the compounds of the invention, which comprise at least one structure of formula (I), already have increased solubility in these solvents.

[0095] The compounds of the present invention can also be mixed with polymers. It is also possible to covalently incorporate these compounds into polymers. This is especially possible for compounds substituted with reactive leaving groups such as bromine, iodine, chlorine, boronic acid or boronic ester, or with reactive polymerizable groups such as olefins or oxetanes. They find use as monomers for producing the corresponding oligomers, dendrimers or polymers. The oligomerization or polymerization is preferably carried out via halogen or boronic acid functional groups, or via polymerizable groups. It is possible to further crosslink the polymer via such groups. The compounds and polymers of the present invention can be used in the form of crosslinked or non-crosslinked layers.

[0096] The present invention further provides polymers, oligomers or dendrimers comprising one or more structures of formula (I) or compounds of the invention as detailed above, in which there are one or more bonds to the compounds of the invention or to the structures of formula (I) to the oligomer, polymer or dendrimer, by linking the structures or compounds of formula (I) they thus form side chains of the polymer or oligomer or are attached within the backbone. The polymers, oligomers or dendrimers may be conjugated, partially conjugated or non-conjugated. The oligomers or polymers may be linear, branched or dendritic. For the repeat units of the compounds of the invention in oligomers, dendrimers and polymers the same preferred forms apply as described above.

[0097] To prepare oligomers or polymers, the monomers of the invention are homopolymerized or copolymerized with further monomers. The units of formula (I) or the preferred forms described above and below are preferably present in the range of 0.01 to 99.9 mol %, preferably 5 to 90 mol %, more preferably 20 to 80 mol %. Suitable and preferred comonomers forming the polymer backbone are fluorenes (for example according to EP 842208 or WO 2000 / 022026), spirobifluorenes (for example according to EP 707020, EP 894107 or WO 2006 / 061181), paraphenylenes (for example according to WO 92 / 18552), carbazoles (for example according to WO 2004 / 070772 or WO 2004 / 113468), thiophenes ( For example, according to EP1028136), dihydrophenanthrenes (for example, according to WO2005 / 014689), cis- and trans-indenofluorenes (for example, according to WO2004 / 041901 or WO2004 / 113412), ketones (for example, according to WO2005 / 040302), phenanthrenes (for example, according to WO2005 / 104264 or WO2007 / 017066), or a plurality of these units. The polymers, oligomers and dendrimers may also contain further units, for example hole transport units, in particular those based on triarylamine, and / or electron transport units.

[0098] Furthermore, of particular interest are compounds of the invention characterized by a high glass transition temperature. In this connection, preference is given to compounds of the invention comprising a structure of formula (I) or of the preferred forms described above and below, which have a glass transition temperature (measured according to DIN 51005 (2005-08 edition)) of at least 70°C, more preferably at least 110°C, even more preferably at least 125°C, and especially preferably at least 150°C.

[0099] To process the compounds of the invention in liquid phase, for example by spin-coating or printing methods, a formulation of the compounds of the invention is required. These formulations can be, for example, solutions, dispersions or emulsions. For this purpose, it is preferable to use a mixture of two or more solvents. Suitable and preferred solvents are, for example, toluene, anisole, o-, m- or p-xylene, methyl benzoate, mesitylene, tetralin, veratrole, THF, methyl-THF, THP, chlorobenzene, dioxane, phenoxytoluene, in particular 3-phenoxytoluene, (-)-fenchone, 1,2,3,5-tetramethylbenzene, 1,2,4,5-tetramethylbenzene, 1-methylnaphthalene, 2-methylbenzothiazole, 2-phenoxyethanol, 2-pyrrolidinone, 3-methylanisole, 4-methylanisole, 3,4-dimethylanisole, 3,5-dimethylanisole, acetophenone, α-terpineol, benzothiazole, butyl benzoate, cumene, cyclohexanol, cyclohexanone ... Examples of the solvent include cyclohexane, cyclohexanediol ...

[0100] Therefore, the present invention also relates to a formulation comprising the compound of the present invention and at least one further compound.The further compound is, for example, a solvent, in particular one of the above-mentioned solvents or a mixture of these solvents.Alternatively, the further compound can be an organic or inorganic compound, for example a light-emitting compound, in particular a phosphorescent dopant, and / or a further matrix material, which are also used in electronic devices.This further compound can also be a polymer.

[0101] Therefore, the present invention further provides a composition comprising the compound of the present invention and at least one additional organic functional material.The functional material is generally an organic or inorganic material that is introduced between the anode and the cathode.Preferably, the organic functional material is selected from the group consisting of fluorescent emitter, phosphorescent emitter, host material, matrix material, electron transport material, electron injection material, hole conducting material, hole injection material, electron blocking material, hole blocking material, wide band gap material and n-dopant.

[0102] The present invention therefore also relates to a composition comprising at least one compound comprising a structure of formula (I) or the preferred forms described above and below, the preferred forms of which are described above and below, and at least one further matrix material, in a particular embodiment of the present invention, the further matrix material having hole transport properties.

[0103] The present invention further provides compositions comprising at least one compound comprising at least one of the structures of formula (I) or preferred forms described above and below, and at least one wide band gap material, where wide band gap material is understood to mean the material disclosed in US 7,294,849. These systems show particularly advantageous performance data in electroluminescent devices.

[0104] Preferably, the additional compound has a band gap of 2.5 eV or more, preferably 3.0 eV or more, and most preferably 3.5 eV or more. One method of calculating the band gap uses the energy levels of the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO).

[0105] Molecular orbitals, especially the highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO), their energy levels and the energy of the lowest triplet state T1 or the lowest excited singlet state S1 of the material are determined using quantum chemical calculations. To calculate metal-free organic substances, first, the structure optimization is performed using the "ground state / semi-empirical / initial spin / AM1 / charge 0 / spin singlet" method. Then, the energy calculation is performed based on the optimized structure. Here, the "TD-SCF / DFT / initial spin / B3PW91" method is used with the "6-31G(d)" basis set (charge 0, spin singlet). For metal-containing compounds, the structure is optimized using the "ground state / Hartree-Fock / initial spin / LanL2MB / charge 0 / spin singlet" method. The energy calculations are performed similarly to the method for organic materials described above, except that the "LanL2DZ" basis set is used for the metal and "6-31G(d)" for the ligand. The HOMO energy level HEh or LUMO energy level LEh is obtained from the energy calculation in Hartree units. This is used to determine the HOMO and LUMO energy levels in electron volts by calibrating with cyclic voltammetry measurements as follows: HOMO(eV)=((HEh*27.212)-0.9899) / 1.1206 LUMO(eV)=((LEh*27.212)-2.0041) / 1.385

[0106] In the context of the present invention, these values ​​are considered to be the HOMO and LUMO energy levels of the material.

[0107] The lowest triplet state T1 is defined as the energy of the triplet state with the lowest energy evident from the quantum chemical calculations given.

[0108] The lowest excited singlet state S1 is defined as the energy of the excited singlet state with the lowest energy evident from the described quantum chemical calculations.

[0109] The method described here is independent of the software package used and will always give the same results. Examples of programs frequently used for this purpose include "Gaussian09W" (Gaussian) and Q-Chem4.1 (Q-Chem).

[0110] The present invention further provides a composition comprising at least one compound comprising at least one structure of formula (I) or the preferred forms described above and below, and at least one phosphorescent emitter, where the term "phosphorescent emitter" is also understood to mean a phosphorescent dopant.

[0111] In a system comprising a matrix material and a dopant, the dopant is understood to mean the component which has the smaller proportion in the mixture. Correspondingly, in a system comprising a matrix material and a dopant, the matrix material is understood to mean the component which has the greater proportion in the mixture.

[0112] Preferred phosphorescent dopants for use in the matrix system, preferably the mixed matrix system, are the preferred phosphorescent dopants specified below.

[0113] The term "phosphorescent dopant" typically encompasses compounds in which emission occurs via a spin-forbidden transition, such as from an excited triplet state, or a state with a higher spin quantum number, such as a quintet state.

[0114] Suitable phosphorescent compounds (= triplet emitters) are compounds that emit light, preferably in the visible range, when appropriately excited, and furthermore contain at least one atom with atomic number greater than 20, preferably greater than 38 and less than 84, more preferably greater than 56 and less than 80, in particular a metal with this atomic number. The phosphorescent emitters used are preferably compounds containing copper, molybdenum, tungsten, rhenium, ruthenium, osmium, rhodium, iridium, palladium, platinum, silver, gold or europium, in particular compounds containing iridium or platinum. In the context of the present invention, all luminescent compounds containing the above metals are considered as phosphorescent compounds.

[0115] Examples of the above-mentioned illuminants are described in WO00 / 70655, WO2001 / 41512, WO2002 / 02714, WO2002 / 15645, EP1191613, EP1191612, EP1191614, WO05 / 033244, WO05 / 019373, US2005 / 0258742, WO2009 / 146770, WO2010 / 015307, WO2010 / 031485, WO2010 / 054731, WO2010 / 054728, WO2010 / 086089, WO No. 6,393,992, and incorporated herein by reference in its entirety. These and other related applications can be found in the following patent applications: WO2010 / 099852, WO2010 / 102709, WO2011 / 032626, WO2011 / 066898, WO2011 / 157339, WO2012 / 007086, WO2014 / 008982, WO2014 / 023377, WO2014 / 094961, WO2014 / 094960, as well as the unpublished applications EP13004411.8, EP14000345.0, EP14000417.7 and EP14002623.8. In general, all phosphorescent complexes as used in the prior art for phosphorescent OLEDs and as further known to those skilled in the art in the field of organic electroluminescent devices are suitable, and those skilled in the art can use further phosphorescent complexes without inventive ingenuity.

[0116] Explicit examples of phosphorescent dopants are given in the table below: [ka]

change

change

change

change

change

change

change

[0117] The above-mentioned compound comprising the structure of formula (I) or the preferred form detailed above can be preferably used as an active component in an electronic device. An electronic device is understood to be a device comprising an anode, a cathode, and at least one layer between the anode and the cathode, said layer comprising at least one organic or organometallic compound. Thus, the electronic device of the present invention comprises an anode, a cathode, and an intermediate layer comprising at least one compound comprising the structure of formula (I). Preferred electronic devices here are selected from the group consisting of organic electroluminescent devices (OLEDs, PLEDs), organic integrated circuits (O-ICs), organic field effect transistors (O-FETs), organic thin film transistors (O-TFTs), organic light emitting transistors (O-LETs), organic solar cells (O-SCs), organic optical detectors, organic photoreceptors, organic field quenching devices (O-FQDs), organic electrical sensors, light emitting electrochemical cells (LECs), organic laser diodes (O-lasers), and organic plasmonic light emitting devices (DM Koller et al., Nature Pho~nics 2008, 1-4), preferably organic electroluminescent devices (OLEDs, PLEDs), in particular phosphorescent OLEDs containing at least one compound comprising the structure of formula (I). Particularly preferred are organic electroluminescent devices. Active components are generally organic or inorganic materials introduced between the anode and the cathode, such as charge-injecting, charge-transporting or charge-blocking materials, but especially light-emitting materials and matrix materials.

[0118] A preferred embodiment of the present invention is an organic electroluminescent device. The organic electroluminescent device comprises an anode, a cathode and at least one light-emitting layer. In addition to these layers, the organic electroluminescent device may also comprise further layers, for example, in each case, one or more hole injection layers, hole transport layers, hole blocking layers, electron transport layers, electron injection layers, exciton blocking layers, electron blocking layers, charge generating layers and / or organic or inorganic p / n junctions. In this case, one or more hole transport layers can be p-doped, for example with metal oxides such as MoO3 or WO3 or with electron-deficient (per)fluorinated aromatic systems, and / or one or more electron transport layers can be n-doped. Similarly, an intermediate layer, which has, for example, an exciton blocking function and / or controls the charge balance in the organic electroluminescent device, may be introduced between the two light-emitting layers. However, it should be noted that each of these layers does not necessarily have to be present.

[0119] Here, the organic electroluminescent element may comprise one light-emitting layer or may comprise multiple light-emitting layers. If multiple light-emitting layers are present, they preferably have multiple emission maxima over the entire range from 380 nm to 750 nm, so as to produce white light overall, i.e., various light-emitting compounds capable of emitting fluorescence or phosphorescence are used in the light-emitting layers. Particularly preferred are three-layer systems (for basic structures, see, for example, WO2005 / 011013) in which the three layers emit blue, green and orange or red light, or systems with three or more light-emitting layers. The system may be a hybrid structure in which one or more layers emit fluorescence and one or more other layers emit phosphorescence.

[0120] In a preferred embodiment of the present invention, the organic electroluminescent device comprises the compound of the present invention comprising the structure of formula (I) or the preferred embodiments detailed above as a matrix material, preferably as an electron-conducting matrix material, in one or more light-emitting layers, preferably in combination with a further matrix material, preferably a hole-conducting matrix material. In a further preferred embodiment of the present invention, the further matrix material is an electron-transporting compound. Yet in a further preferred embodiment, the further matrix material is a compound with a large band gap that is not or not to a significant extent involved in hole and electron transport in the layer. The light-emitting layer comprises at least one light-emitting compound.

[0121] Suitable matrix materials which can be used in combination with the compounds of formula (I) or according to the preferred embodiments are aromatic ketones; aromatic phosphine oxides; or aromatic sulfoxides or sulfones (for example according to WO 2004 / 013080, WO 2004 / 093207, WO 2006 / 005627 or WO 2010 / 006680); triarylamines, in particular monoamines (for example according to WO 2014 / 015935); carbazole derivatives (for example CBP (N,N-biscarbazolylbiphenyl) or carbazole derivatives as disclosed in WO2005 / 039246, US2005 / 0069729, JP2004 / 288381, EP1205527, or WO2008 / 086851; indolocarbazole derivatives (for example according to WO2007 / 063754 or WO2008 / 056746); indenocarbazole derivatives (for example according to WO2010 / 136109 and WO2011 / 000455); azacarbazole derivatives (for example according to EP1617710, EP1617711, EP1731584, JP 2005 / 347160; bipolar matrix materials (for example according to WO2007 / 137725); silanes (for example according to WO2005 / 111172); azaboroles or boronic esters (for example according to WO2006 / 117052); triazine derivatives (for example according to WO2010 / 015306, WO2007 / 063754 or WO2008 / 056746); zinc complexes (for example according to EP652273 or WO2009 / 062578); diazasilol or tetraazasilol derivatives. diazaphosphole derivatives (for example according to WO2010 / 054730); bridged carbazole derivatives (for example according to US2009 / 0136779, WO2010 / 050778, WO2011 / 042107, WO2011 / 088877 or WO2012 / 143080); triphenylene derivatives (for example according to WO2012 / 048781); lactams (for example according to WO2011 / 116865, WO2011 / 137951 or WO2013 / 064206);Or 4-spirocarbazole derivatives (for example according to WO2014 / 094963 or unpublished application EP14002104.9). It is also possible for further phosphorescent emitters, which emit at shorter wavelengths than the actual emitter, to be present in the mixture as co-hosts;

[0122] Preferred co-host materials are triarylamine derivatives, especially monoamines, indenocarbazole derivatives, 4-spirocarbazole derivatives, lactams, and carbazole derivatives.

[0123] Preferred triarylamine derivatives to be used as co-host materials together with the compounds of the present invention are selected from the compounds of the following formula (TA-1): [ka] In the formula, Ar 1 are identical or different at each occurrence, have 6 to 40 carbon atoms, and in each case, one or more R 2 Aromatic or heteroaromatic ring systems, optionally substituted by radicals, having 5 to 60 aromatic ring atoms and one or more R 2 an aryloxy group, optionally substituted by a radical, or an aryloxy group having 5 to 60 aromatic ring atoms, in each case one or more R 2 an aralkyl group optionally substituted by a radical, where two or more adjacent R 2 is optionally monocyclic or polycyclic, 3 and optionally forming an aliphatic ring system substituted by the symbol R 2 has the meaning given above, especially in formula (I). 1 is identical or different at each occurrence and is an aryl or heteroaryl group having 5 to 24, preferably 5 to 12, aromatic ring atoms, and in each case one or more R 2 The radicals may be substituted, but are preferably unsubstituted.

[0124] Appropriate Ar 1 Exemplary groups are phenyl, ortho-, meta- or para-biphenyl, terphenyl, especially branched terphenyl, quaterphenyl, especially branched quaterphenyl, 1-, 2-, 3- or 4-fluorenyl, 1-, 2-, 3- or 4-spirobifluorenyl, pyridyl, pyrimidinyl, 1-, 2-, 3- or 4-dibenzofuranyl, 1-, 2-, 3- or 4-dibenzothienyl and 1-, 2-, 3- or 4-carbazolyl, each of which may be selected from the group consisting of one or more R 2 The radicals may be substituted, but are preferably unsubstituted.

[0125] Preferably, Ar 1 The groups may be the same or different at each occurrence and may be any of the groups R 1 -1~R 1 -80 to preferably R 1 -1~R 1 -51 are selected.

[0126] In a preferred embodiment of the compound represented by formula (TA-1), at least one Ar 1 The group is selected from the group consisting of biphenyl groups, which may be ortho-, meta- or para-biphenyl groups. In a further preferred embodiment of the compound of formula (TA-1), at least one Ar 1 The group is selected from a fluorene group or a spirobifluorene group, where these groups may be bonded to the nitrogen atom in the 1-, 2-, 3- or 4-position, respectively. In an even more preferred embodiment of the compound of formula (TA-1), at least one group Ar 1is selected from a phenylene or biphenyl group which is an ortho-, meta- or para-bonded group and is substituted by a dibenzofuran, benzothiophene or carbazole group, in particular a dibenzofuran group, where the dibenzofuran or benzothiophene group is bonded to the phenylene or biphenyl group via the 1-, 2-, 3- or 4-position and where the carbazole group is bonded to the phenylene or biphenyl group via the 1-, 2-, 3- or 4-position or via a nitrogen atom.

[0127] In a particularly preferred embodiment of the compound of formula (TA-1), one Ar 1 The radical is selected from fluorene or spirobifluorene radicals, in particular from 4-fluorene or 4-spirobifluorene radicals, and one Ar 1 The group is selected from a biphenyl group, in particular a para-biphenyl group, or a fluorene group, in particular a 2-fluorene group, and the third Ar 1 The radicals are selected from para-phenylene or para-biphenyl radicals substituted with a dibenzofuran radical, in particular a 4-dibenzofuran radical, or with a carbazole radical, in particular an N-carbazole radical or a 3-carbazole radical.

[0128] The indenocarbazole derivatives used as co-host materials together with the compounds of the present invention are selected from the compounds of the following formula (TA-2): [ka] In the formula, Ar 1 and R 1 has the meaning given above, in particular for formula (I) and / or (TA-1). 1 A preferred embodiment of the present invention is represented by the above structure R 1 -1~R 1 -80, more preferably R 1 -1~R 1 It is -51.

[0129] A preferred form of the compound of formula (TA-2) is the compound of formula (TA-2a) below: [ka] In the formula, Ar 1 and R 1 has the meaning given above, in particular for formula (I) and / or (TA-1), in which two R 1 The radicals are preferably, identical or different, alkyl radicals having 1 to 4 carbon atoms, in particular a methyl radical, or an aromatic ring system having 6 to 12 carbon atoms, in particular a phenyl radical. More preferably, the two R 1 More preferably, the R bonded to the indenocarbazole basic skeleton in formula (TA-2a) is a methyl group. 1 The substituents are H or a carbazole group which can be bonded to the indenocarbazole base skeleton via the 1-, 2-, 3- or 4-position or via a nitrogen atom, in particular via the 3-position.

[0130] Preferred 4-spirocarbazole derivatives to be used as co-host materials together with the compounds of the present invention are selected from the compounds of formula (TA-3): [ka] In the formula, Ar 1 and R 1 has the meaning given above, in particular for formulae (I), (II) and / or (Q-1). 1 A preferred form of the group is the structure (R 1 -1)~(R 1 -80), more preferably R 1 -1~R 1 It is -51.

[0131] A preferred form of the compound of formula (TA-3) is the compound of formula (TA-3a): [ka] In the formula, Ar 1 and R 1 has the meaning given above, in particular for formulae (I), (II) and / or (Q-1). 1 A preferred form of the group is the structure (R 1 -1)~(R 1 -80), more preferably R 1 -1~R 1 It is -51.

[0132] The lactams used as co-host materials together with the compounds of the present invention are selected from the compounds of formula (LAC-1): [ka] In the formula, R 1 has the meaning given above, especially in formula (I).

[0133] A preferred form of the compound of formula (LAC-1) is the compound of formula (LAC-1a): [ka] In the formula, R 1 has the meaning given above, in particular in formula (I). 1 is preferably identical or different at each occurrence and is H or has 5 to 40 aromatic ring atoms and one or more radicals R 2 an aromatic or heteroaromatic ring system, optionally substituted with R 2 has the meaning given above, in particular in formula (I). Most preferably, R 1 The substituents are selected from H and 6 to 18 aromatic ring atoms, preferably 6 to 13 aromatic ring atoms, each of which is substituted with one or more non-aromatic radicals R 2 The appropriate R is selected from the group consisting of aromatic or heteroaromatic ring systems, which may be substituted, but are preferably unsubstituted. 1Examples of substituents are phenyl, ortho-, meta- or para-biphenyl, terphenyl, especially branched terphenyl, quaternary phenyl, especially branched quaternary phenyl, 1-, 2-, 3- or 4-fluorenyl, 1-, 2-, 3- or 4-spirobifluorenyl, pyridyl, pyrimidinyl, 1-, 2-, 3- or 4-dibenzofuranyl, 1-, 2-, 3- or 4-dibenzothienyl, 1-, 2-, 3- or 4-carbazolyl (each of which may be selected from the group consisting of one or more R 2 The appropriate structure R is selected from the group consisting of: 1 R-1 to R-79, more preferably R 1 -1~R 1 It is the same structure as shown for -51.

[0134] It is also preferred to use mixtures of different matrix materials, in particular at least one electron-conducting matrix material and at least one hole-conducting matrix material, as well as mixtures of charge-transporting matrix materials with electrically inactive matrix materials which are not involved to any significant extent, if at all, in the charge transport, as described, for example, in WO 2010 / 108579.

[0135] Furthermore, the use of a mixture of two or more triplet emitters and matrices is preferred, where a triplet emitter with a shorter wavelength emission spectrum acts as a co-matrix for a triplet emitter with a longer wavelength emission spectrum.

[0136] More preferably, the compounds of the present invention comprising the structure of formula (I) in a preferred form can be used as a matrix material in an organic electronic device, in particular an organic electroluminescent device, such as an OLED or OLEC, in an emitting layer, in which the matrix material comprising the structure of formula (I) or the preferred forms described above and below is present in the electronic device in combination with one or more dopants, preferably phosphorescent dopants.

[0137] In this case, the ratio of the matrix material in the light-emitting layer is 50.0 to 99.9 volume %, preferably 80.0 to 99.5 volume %, and more preferably 92.0 to 99.5 volume % for the fluorescent-emitting layer, and 85.0 to 97.0 volume % for the phosphorescent-emitting layer.

[0138] Correspondingly, the proportion of the dopant is 0.1 to 50.0 volume %, preferably 0.5 to 20.0 volume %, and more preferably 0.5 to 8.0 volume % for the fluorescent-emitting layer, and 3.0 to 15.0 volume % for the phosphorescent-emitting layer.

[0139] The light-emitting layer of the organic electroluminescent device may also be a system that contains several matrix materials (mixed matrix system) and / or several dopants. In this case, too, the dopant is generally the material that has a smaller proportion in the system, and the matrix material is the material that has a larger proportion in the system. However, in individual cases, the proportion of a single matrix material in the system may be smaller than the proportion of a single dopant.

[0140] In a further preferred embodiment of the invention, the compound comprising the structure of formula (I) or the preferred embodiments described above and below is used as one component of a mixed matrix system. The mixed matrix system preferably comprises two or three different matrix materials, more preferably two different matrix materials. In this case, it is preferred that one of the two materials is a material with hole transport properties and the other material is a material with electron transport properties. However, the desired electron transport and hole transport properties of the mixed matrix component may also be mainly or completely incorporated in a single mixed matrix component, in which case the further mixed matrix component(s) fulfills the other function. The two different matrix materials may be present in a ratio of 1:50 to 1:1, preferably 1:20 to 1:1, more preferably 1:10 to 1:1 and most preferably 1:4 to 1:1. It is preferred to use the mixed matrix system in a phosphorescent organic electroluminescent device. More detailed information on the mixed matrix system is given, inter alia, in application WO2010 / 108579.

[0141] The present invention further provides an electronic device, preferably an organic electroluminescent device, comprising, as electronically conductive compound in one or more electronically conductive layers, one or more of the compounds according to the invention and / or at least one oligomer, polymer or dendrimer according to the invention.

[0142] The cathode is preferably a metal, metal alloy or multilayer structure composed of various metals, such as alkaline earth metals, alkali metals, metals of the main group or lanthanides (e.g. Ca, Ba, Mg, Al, In, Mg, Yb, Sm, etc.), having a low work function. Also suitable are alloys composed of alkali metals or alkaline earth metals and silver, for example alloys composed of magnesium and silver. In the case of multilayer structures, in addition to the metals, further metals with a relatively high work function, such as Ag, can also be used, in which case combinations of metals such as Mg / Ag, Ca / Ag or Ba / Ag are commonly used. Also, a thin intermediate layer, preferably composed of a material with a high dielectric constant, can be introduced between the metal cathode and the organic semiconductor. Examples of suitable materials for this purpose are fluorides of alkali metals or alkaline earth metals, and also the corresponding oxides or carbonates (e.g. LiF, Li2O, BaF2, MgO, NaF, CsF, Cs2CO3, etc.). Also useful for this purpose are organic alkali metal complexes, such as Liq (lithium quinolinate).The layer thickness of this layer is preferably 0.5 to 5 nm.

[0143] The anode is preferably a material with a high work function. The anode preferably has a work function greater than 4.5 eV relative to vacuum. Firstly, metals with high redox potentials, such as Ag, Pt or Au, are suitable for this purpose. Secondly, metal / metal oxide electrodes (e.g. Al / Ni / NiOx, Al / P~x) are also preferred. For some applications, at least one electrode must be transparent or partially transparent to allow either the irradiation of the organic material (O-SC) or the emission of light (OLED / PLED, O-laser). Here, preferred anode materials are conductive mixed metal oxides. Particularly preferred are indium tin oxide (ITO) or indium zinc oxide (IZO). Furthermore, preferred are doped conductive organic materials, in particular doped conductive polymers, such as PEDOT, PANI or derivatives of these polymers. It is further preferred when a p-type doped hole transport material is applied to the anode as a hole injection layer, in which case suitable p-dopants are metal oxides, such as MoO3 or WO3, or electron-deficient (per)fluorinated aromatic systems. Further suitable p-dopants are HAT-CN (hexacyanohexaazatriphenylene) or the compound NPD9 from Novaled. Such a layer simplifies hole injection into a material with a low HOMO, ie, a HOMO that is large in magnitude.

[0144] In the further layers, any material used in the prior art for such layers can generally be used, and the skilled person can combine any of these materials with the materials according to the invention in an electronic device without inventive ingenuity.

[0145] Since the service life of such components is significantly shortened by the presence of water and / or air, the components are accordingly structured (depending on the application), provided with contacts and finally hermetically sealed.

[0146] Further preferred are electronic devices, in particular organic electroluminescent devices, characterized in that one or more layers are applied by sublimation. -5 Less than millibars, preferably 10 -6 It is applied by vacuum deposition in a vacuum sublimation system at an initial pressure of less than mbar. The initial pressure can be lower or higher, for example 10 -7Submillibars are also possible.

[0147] Also preferred are electronic devices, in particular organic electroluminescent devices, characterized in that one or more layers are applied by the OVPD (organic vapor phase deposition) method or by means of sublimation of a carrier gas. -5 It is applied at pressures of mbar to 1 bar. A special case of this method is the OVJP (Organic Vapor Jet Printing) method, in which the material is applied directly through a nozzle and further structured (e.g., MS Arnold et al., Appl. Phys. Lett. 2008, 92, 053301).

[0148] Further preferred are electronic devices, in particular organic electroluminescent devices, characterized in that one or more layers are produced from solution, for example by spin coating or by any printing method, for example by screen printing, flexographic printing, offset printing or nozzle printing, but more preferably by LITI (light-induced thermal imaging, thermal transfer printing) or inkjet printing. For this purpose, soluble compounds are required, which can be obtained, for example, by suitable substitution.

[0149] Electronic devices, in particular organic electroluminescent devices, can also be produced as hybrid systems by coating one or more layers from solution and one or more other layers by vacuum deposition, for example an emissive layer comprising a compound of formula (I) and a matrix material can be coated from solution and thereto a hole blocking layer and / or an electron transporting layer can be coated by vacuum deposition under reduced pressure.

[0150] These methods are generally known to those skilled in the art and can be readily applied to electronic devices, particularly organic electroluminescent devices, comprising compounds of formula (I) or the preferred forms detailed above.

[0151] The electronic devices, in particular organic electroluminescent devices, according to the present invention are notable for one or more of the following surprising advantages over the prior art:

[0152] 1. Electronic devices, in particular organic electroluminescent devices, comprising a compound, oligomer, polymer or dendrimer having the structure of formula (I) or the preferred forms described above and below, in particular as an electron conducting material, have a very good life span.

[0153] 2. An electronic device, particularly an organic electroluminescent device, comprising a compound, oligomer, polymer or dendrimer having the structure of formula (I) or the preferred forms described above and below as an electron conducting material, electron injecting material and / or electron blocking material has excellent efficiency, more specifically, is much higher than that of a similar compound that does not contain the structural unit of formula (I).

[0154] 3. The compounds, oligomers, polymers or dendrimers of the present invention having the structure of formula (I) or the preferred forms described above and below, exhibit very high stability and result in compounds with very long lifetimes.

[0155] 4. The use of compounds, oligomers, polymers or dendrimers having the structure of formula (I) or the preferred forms described above and below makes it possible to avoid the formation of light loss channels in electronic devices, in particular in organic electroluminescent devices, so that these devices are characterized by high PL efficiency and thus high EL efficiency of the emitter, as well as good energy conduction from the matrix to the dopant.

[0156] 5. The use of compounds, oligomers, polymers or dendrimers having the structure of formula (I) or the preferred forms described above and below in layers of electronic devices, in particular organic electroluminescent devices, results in high mobility of electronically conductive structures.

[0157] 6. Compounds, oligomers, polymers or dendrimers having the structure of formula (I) or the preferred forms described above and below are characterized by excellent thermal stability, and compounds having a molecular weight of less than about 1200 g / mol have good sublimability.

[0158] 7. The compounds, oligomers, polymers or dendrimers having the structure of formula (I) or the preferred forms described above and below have excellent glass film forming properties.

[0159] 8. Compounds, oligomers, polymers or dendrimers having the structure of formula (I) or the preferred forms described above and below form very good films from solution.

[0160] 9. Compounds, oligomers, polymers or dendrimers comprising the structure of formula (I) or the preferred forms described above and below have surprisingly high triplet levels T1, in particular for compounds used as electronically conductive materials.

[0161] These above mentioned advantages are not accompanied by degradation of other electronic properties.

[0162] The compounds and mixtures of the present invention are suitable for use in electronic devices. Electronic devices are understood to mean devices that contain at least one layer that contains at least one organic compound. Devices may also contain layers that contain inorganic materials or are entirely made of inorganic materials.

[0163] The present invention therefore provides the use of the compounds or mixtures according to the invention in electronic devices, in particular organic electroluminescent devices.

[0164] The present invention still further provides the use of a compound according to the invention and / or an oligomer, polymer or dendrimer according to the invention as hole blocking, electron injection and / or electron transport material in an electronic device.

[0165] The present invention further provides an electronic device comprising at least one of the compounds or mixtures of the present invention as shown above. In this case, the preferred compounds as described above are also applied to the electronic device. More preferably, the electronic device is selected from the group consisting of organic electroluminescent devices (OLED, PLED), organic integrated circuits (O-IC), organic field effect transistors (O-FET), organic thin film transistors (O-TFT), organic light emitting transistors (O-LET), organic solar cells (O-SC), organic photodetectors, organic photoreceptors, organic field quenching devices (O-FQD), organic electric sensors, light emitting electrochemical cells (LEC), organic laser diodes (O-laser), and organic plasmonic light emitting devices (DMKoller et al., Nature Pho~nics 2008, 1-4), preferably organic electroluminescent devices (OLED, PLED), in particular phosphorescent OLED.

[0166] In a further embodiment of the present invention, the organic electroluminescent device of the present invention does not include a separate hole injection layer and / or hole transport layer and / or hole blocking layer and / or electron transport layer, which means that the light-emitting layer is directly adjacent to the hole injection layer or the anode, and / or the light-emitting layer is directly adjacent to the electron transport layer or the electron injection layer or the cathode, as described, for example, in WO2005 / 053051.Furthermore, the same or similar metal complex as the metal complex in the light-emitting layer can also be used as a hole transport or hole injection material directly adjacent to the light-emitting layer, as described, for example, in WO2009 / 030981.

[0167] The compounds of the present invention can also be used in hole blocking or electron transport layers. This is especially true for the compounds of the present invention that do not have a carbazole structure. They may also be preferably substituted with one or more further electron transport groups, such as benzimidazole.

[0168] In the further layer of the organic electroluminescent device of the present invention, any material as is commonly used according to the prior art can be used.Therefore, those skilled in the art can use any material known for organic electroluminescent devices in combination with the compound of the present invention according to formula (I) or preferred form without inventive ingenuity.

[0169] The compounds of the invention generally have very good properties when used in organic electroluminescent devices.In particular, when the compounds of the invention are used in organic electroluminescent devices, the lifetime is significantly better than that of similar compounds according to the prior art.At the same time, other properties of organic electroluminescent devices, especially efficiency and voltage, are also better or at least comparable.

[0170] It should be noted that variations on the described embodiments of the present invention are included within the scope of the present invention. Each feature disclosed in the present invention may be replaced with an alternative feature serving the same purpose or an equivalent or similar purpose, unless this is expressly excluded. Therefore, each feature disclosed in the present invention should be considered as an example of a generic series, or an equivalent or similar feature, unless otherwise stated.

[0171] All features of the present invention can be combined with one another in any way, unless the particular features and / or steps are mutually exclusive. This is particularly true for the preferred features of the present invention. Similarly, features of non-essential combinations can be used separately (and not in combination).

[0172] It should be noted that many features, and in particular features of the preferred forms of the invention, are inventive in themselves and should not be considered as being solely part of the form of the invention, and that these features may claim independent protection in addition to or instead of the invention as currently claimed.

[0173] The technical teachings disclosed with the present invention may be abstracted and combined with other embodiments.

[0174] The present invention will now be described in more detail with reference to the following examples, without however limiting the invention thereto.

[0175] Using the following detailed description, one skilled in the art can, without inventive elaboration, further manufacture the electronic device of the present invention and thereby practice the present invention throughout the scope of the claims.

[0176] Working Example The following syntheses are carried out in dry solvents under protective gas atmosphere unless otherwise stated. Reagents can be purchased, for example, from Aldrich (potassium fluoride (spray-dried), tri-tert-butylphosphine, palladium(II) acetate). Spiro-9,9'-bifluorene-2,7-bis(boronic acid glycol ester) is prepared analogously to WO2002 / 077060. The numbers of compounds known from the literature (some are shown in square brackets) are the corresponding CAS numbers.

[0177] Synthesis Example Example 1: Synthesis of 4-[3-(9H,9'H-[9,9']bifluorenyl-2-yl)phenyl]-2,6-diphenylpyrimidine [ka]

[0178] Step a) Synthesis of spiro-9,9'-bifluorene-2-boronic acid To a solution of 103 g (264 mmol) of 2-bromo-9-spirobifluorene in 1500 ml of diethyl ether cooled to -78 ° C, 107 ml (2764 mmol) of n-butyllithium (2.5 M in hexane) are added dropwise. The reaction mixture is stirred at -78 ° C for 30 minutes. The mixture is left to reach room temperature and cooled again to -78 ° C, after which a mixture of 40 ml (351 mmol) of trimethyl borate in 50 ml of diethyl ether is added quickly. After warming to -10 ° C, it is hydrolyzed with 135 ml of 2N hydrochloric acid. The organic phase is separated, washed with water, dried over sodium sulfate and concentrated to dryness. The residue is taken up in 300 ml of n-heptane and the colorless solid is suction filtered, washed with n-heptane and dried under reduced pressure. Yield: 93.4 g (249 mmol), 97% of theory. Purity: 99% by HPLC. By a similar method, the following compounds can be obtained: [ka]

[0179] The reactants from a4 can be obtained by the following reaction: [ka] To a solution of 2-bromo-4'-cyclobiphenyl (105.4 g, 0.394 mol) in 1.5 L of THFabs. cooled to -78°C, n-BuLi (157.6 ml, 2.5 M, 0.394 mol) is added dropwise within 45 min. After 40 min at -74°C, 2-phenylfluorenone (101.0 g, 0.394 mol) is added in portions as a solid within 1 h. The mixture is allowed to warm to room temperature overnight and then the mixture is carefully mixed with 100 ml of ammonium chloride and 100 ml of distillate. In a separatory funnel, another 500 ml of distillate is added to the THF phase. The aqueous phase is removed. The organic THF phase is concentrated in vacuum. The aqueous phase is extracted three times with ethyl acetate. The flask residue of the THF phase is dissolved in 2 L of ethyl acetate and washed three times with 750 ml of distillate. All combined organic phases were dried over sodium sulfate and concentrated to a residue (152.5 g, 0.342 mol, 87%), which was further directly converted.

[0180] 9-(4'-chlorobiphenyl-2-yl)-2-phenyl-9H-fluoren-9-ol (120.0 g, 0.270 mol) is initially charged in glacial acetic acid (2.2 L), hydrochloric acid (0.2 L) is added and the mixture is heated under reflux for 2 h. The mixture is cooled to room temperature, 1.5 L of pure water is added and the precipitate formed is suction filtered. The filter residue is washed with pure water and the residue is stirred with ethanol. This gives 2'-chloro-2-phenyl-9,9'-spirobi[fluorene] (101 g, 0.236 mol, 87%).

[0181] Step b) Synthesis of 4-[3-(9H,9'H-[9,9']bifluorenyl-2-yl)phenyl]-2,6-diphenylpyrimidine 55.6 g (107 mmol) of spiro-9,9'-bifluorene-2-boronic acid, 41.4 g (107 mmol) of 4-(3-bromophenyl)-2,6-diphenylpyrimidine and 44.6 g (210.0 mmol) of tripotassium phosphate are suspended in 500 ml of toluene, 500 ml of dioxane and 500 ml of water. To this suspension, 913 mg (3.0 mmol) of tri-o-tolylphosphine and 112 mg (0.5 mmol) of palladium(II) acetate are added and the reaction mixture is heated under reflux for 16 hours. After cooling, the organic phase is removed, filtered through silica gel, washed three times with 200 ml of water, dried and concentrated. The residue is recrystallized from toluene and dichloromethane / isopropanol and finally sublimed under high vacuum (p=5x10 -5 mbar, T = 377°C). The yield was 37.7 g (42.1 mmol), corresponding to 87% of theory.

[0182] The following compounds can be obtained in a similar manner: [ka] [ka] [ka] [ka] [ka] [ka] [ka] [ka]

[0183] OLED manufacturing Examples C1-I10 below (see Tables 1 and 2) provide data for various OLEDs.

[0184] Pretreatment of Examples C1-I10: To improve the process, glass plates coated with 50 nm thick structured I~ (indium tin oxide) are coated with 20 nm PEDOT:PSS (poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate), purchased as CLEVIOS™ P VP AI 4083 from Heraeus Precious Metals GmbH, Germany, spin-coated from an aqueous solution). These coated glass plates form the substrates on which the OLEDs are applied.

[0185] An OLED basically has the following layer structure: substrate / hole transport layer (HTL) / optional interlayer (IL) / electron blocking layer (EBL) / emissive layer (EML) / optional hole blocking layer (HBL) / electron transport layer (ETL) / optional electron injection layer (EIL) and finally a cathode. The cathode is formed of a 100 nm thick layer of aluminum. The exact structure of the OLED can be found in Table 1. The materials required for the manufacture of the OLED are given in Table 3.

[0186] All materials are applied by thermal evaporation in a vacuum chamber. Here, the light-emitting layer always consists of at least one matrix material (host material) and a light-emitting dopant (emitter) that is mixed in a certain volume proportion into the matrix material(s) by co-evaporation. A specification given in the form IC1:IC3:TEG1 (55%:35%:10%) means here that the material IC1 is present in the layer in a volume proportion of 55%, IC3 is present in the layer in a volume proportion of 35% and TEG1 is present in the layer in a volume proportion of 10%. Similarly, the electron transport layer may also consist of a mixture of two materials, the numbers being the volume proportions as well.

[0187] OLEDs are characterized by standard methods, which involve determining the electroluminescence spectrum, the current efficiency (measured in cd / A), the power efficiency (measured in lm / W) and the external quantum efficiency (EQE, measured as a percentage) as a function of luminous density calculated from the current-voltage-luminous flux density characteristic line (IUL characteristic line) assuming a Lambertian emission characteristic. The electroluminescence spectrum is calculated for a luminous flux density of 1000 cd / m 2 From this, the x and y color coordinates are calculated according to the CIE 1931 standard. The parameter U1000 in Table 2 is 1000 cd / m 2 CE1000 and PE1000 represent the voltage required for a luminous flux density of 1000cd / m 2 Finally, EQE1000 represents the current and voltage efficiency achieved at an operating luminous flux density of 1000 cd / m 2 The external quantum efficiency at

[0188] The data for various OLEDs are summarized in Table 2. Examples C1-C6 are comparative examples according to the prior art, while Examples I1-I10 show data for OLEDs according to the present invention.

[0189] To illustrate the advantages of the OLED according to the present invention, some examples are described in detail below.

[0190] Use of the materials of the present invention as hole-blocking layers in OLEDs When the materials of the present invention are used as hole blocking layers in OLEDs, they provide a significant improvement in power efficiency over the prior art. By using the compounds IC of the present invention, an increase in power efficiency of about 13-59% can be observed over the prior art PA1, PA2, PA3, PA4, PA5 and PA6 (compared to C1, C2, C3, C4, C5, C6 in experiment I1). For example, an increase of about 19% (=1 / 5.2*100%) can be achieved by using a pyrimidine group (I1) rather than a triazine group (C1). The linking group L 1The use of can lead to an improvement of about 30% (=1.5 / 5.0*100%; I7 compared to C3), 24% (=1.2 / 5.0*100%; I1 compared to C3), 18% (=0.9 / 5.0*100%; I4 compared to C3) or 10% (=0.5 / 5.0*100%; I3 compared to C3). The comparison of I10 and C6 shows in particular the preference for the phenyl linker compared to the triazine linker, which results in an increase in power efficiency of 49% (=1.9 / 3.9*100%). The low efficiency of the comparative example C6 shows that the triazine linker leads to unfavourable properties. At the same time, other properties, in particular the power efficiency (measured in cd / A), the external quantum efficiency (EQE, measured in percent) as a function of luminescence, and the brightness 1000 cd / m 2 The voltage required at is in some cases very significantly improved with the measures of the present invention. [Table 1-1] [Table 1-2] [Table 2] [Table 3-1] [Table 3-2] [Table 3-3]

Claims

1. A compound of formula (IIIb), (IIIc) or (IIId). 【Chemistry 1】 (wherein the symbols used are as follows: m is 0, 1, 2, 3 or 4; n is 0, 1, 2, or 3; Q is selected from structures of formula (Q-8), (Q-9) and / or (Q-10); 【Chemistry 2】 L 1 is selected from the group consisting of ortho-phenylene, meta-phenylene, and para-phenylene, each of which is one or more R 2 may be substituted with a radical; R 1 is different for each occurrence and has the formula (R 1 -1) to (R 1 -80), 【Chemistry 3-1】 【Chemistry 3-2】 【Chemistry 3-3】 【Chemistry 3-4】 【Chemistry 3-5】 【Chemistry 3-6】 (wherein the symbols are as follows: Y is O, S or NR 2 and i is independently at each occurrence 0, 1 or 2; j is independently at each occurrence 0, 1, 2 or 3; h is independently at each occurrence 0, 1, 2, 3 or 4; g is independently at each occurrence 0, 1, 2, 3, 4 or 5; and The dotted lines indicate the connection positions. R 2 are the same or different at each occurrence and are H, D, F, Cl, Br, I, CN, a linear alkyl, alkoxy, or thioalkoxy group having 1 to 40 carbon atoms, or a branched or cyclic alkoxy or thioalkoxy group having 3 to 40 carbon atoms, each of which may be selected from one or more R 3 radical, wherein one or more non-adjacent CH 2 The group is -R 3 C=CR 3 -, -C≡C-, Si(R 3 ) 2 , C=O, C=S, C=NR 3 , -C(=O)O-, -C(=O)NR 3 -, N.R. 3 , P(=O)(R 3 ), —O—, —S—, SO, or SO 2 and one or more hydrogen atoms are replaced by D, F, Cl, Br, I, CN, or NO 2 , or 5 to 40 aromatic ring atoms, and in each case, one or more R 3 an aromatic or heteroaromatic ring system, optionally substituted with a radical, having 5 to 60 aromatic ring atoms and one or more R 3 an aryloxy or heteroaryloxy group, optionally substituted with a radical, or a aryloxy group having 5 to 60 aromatic ring atoms, and in each case one or more R 3 an aralkyl group optionally substituted with a radical, or a combination of these systems, where optionally two or more adjacent R 2 The substituents are one or more monocyclic or polycyclic R 3 may form an aliphatic or aromatic ring system, optionally substituted with radicals, R 3 are identical or different at each occurrence and are H, D, F, or an aliphatic hydrocarbyl radical having 1 to 20 carbon atoms (wherein one or more hydrogen atoms may be replaced by D or F), or an aromatic and / or heteroaromatic ring system having 5 to 30 carbon atoms (wherein one or more hydrogen atoms may be replaced by D or F), where two or more adjacent R 3 The substituents may optionally form a monocyclic or polycyclic, aliphatic or aromatic ring system.

2. 2. The compound of claim 1 having formula (IVb), (IVc) or (IVd). 【Chemistry 4】 (Wherein, symbols m, n, R 1 , L 1 and Q has the meaning given in claim 1.

3. In the structures of formula (IIIb), (IIIc), (IIId), (IVb), (IVc) and / or (IVd), m is 0, 1, or 2; and 3. The compound of claim 1 or 2, wherein n is 0, 1 or 2.

4. In the structures of formula (IIIb), (IIIc), (IIId), (IVb), (IVc) and / or (IVd), m is 0, and The compound according to any one of claims 1 to 3, wherein n is 0.

5. R 1 is different at each occurrence and has 6 to 18 aromatic ring atoms, and in each case one or more non-aromatic R 2 A compound according to any one of claims 1 to 4, selected from the group consisting of aromatic or heteroaromatic ring systems, optionally substituted with radicals.

6. R 1 is different at each occurrence and includes phenyl, ortho-, meta- or para-biphenyl, terphenyl, quaterphenyl, 1-, 2-, 3- or 4-fluorenyl, 1-, 2-, 3- or 4-spirobifluorenyl, pyridyl, pyrimidinyl, 1-, 2-, 3- or 4-dibenzofuranyl, 1-, 2-, 3- or 4-dibenzothienyl, and 1-, 2-, 3- or 4-carbazolyl, each of which may be selected from one or more of R 2 6. The compound according to claim 1, wherein the compound is selected from the group consisting of:

7. The compound according to any one of claims 1 to 6, wherein in formula (Q-8), (Q-9) and / or (Q-10), n is 0, 1 or 2.

8. Compounds according to any one of claims 1 to 7, characterized in that the Q group is selected from formula (Q-13) and / or (Q-14). 【Chemistry 6】 (Wherein, symbol R 1 has the meaning as defined in claim 1 and the dotted line indicates the connection position)

9. In the structures of formula (IIIb), (IIIc), (IIId), (IVb), (IVc) and / or (IVd), L 1 The group is represented by the formula (L 1 9. The compound according to claim 1, wherein the compound is represented by the formula: 【Chemistry 7】 (In the formula, R 2 has the meaning as defined in claim 1 and h is, independently at each occurrence, 0, 1, 2, 3 or 4.

10. In the structures of formula (IIIb), (IIIc), (IIId), (IVb), (IVc) and / or (IVd), L 1 The group is represented by the formula (L 1 -92) ~ (L 1 -94). 【Chemistry 8】 where the dotted line in each case indicates the point of attachment, the subscript h is, independently at each occurrence, 0, 1, 2, 3, or 4, and the symbol R 2 has the meaning given in claim 1)

11. One pyrimidine group is L in the structure of formula (IIIb), (IIIc), (IIId), (IVb), (IVc) and / or (IVd). 1 The compound according to any one of claims 1 to 10, characterized in that it is bound to a group.

12. L in the structures of formula (IIIb), (IIIc), (IIId), (IVb), (IVc) and / or (IVd) 1 A compound according to any one of claims 1 to 10, characterised in that the radical has exactly one pyrimidine group bonded thereto, rather than a pyridine group.

13. Compounds according to any one of claims 1 to 10, characterized in that the compounds having the structure of formula (IIIb), (IIIc), (IIId), (IVb), (IVc) and / or (IVd) comprise one pyridine group.

14. 14. An oligomer, polymer or dendrimer comprising one or more compounds according to any one of claims 1 to 13, wherein there is one or more bonds of said compound to said polymer, oligomer or dendrimer.

15. A composition comprising at least one compound according to any one of claims 1 to 13 and / or an oligomer, polymer or dendrimer according to claim 14 and at least one further compound selected from the group consisting of fluorescent emitters, phosphorescent emitters, matrix materials, electron transport materials, electron injection materials, hole conducting materials, hole injection materials, electron blocking materials and hole blocking materials, wide band gap materials or n-dopants.

16. A formulation comprising at least one compound according to any one of claims 1 to 13, an oligomer, polymer or dendrimer according to claim 14 and / or at least one composition according to claim 15, and at least one solvent.

17. A method for preparing a compound according to any one of claims 1 to 13 or an oligomer, polymer or dendrimer according to claim 14, characterized in that a compound comprising at least one pyrimidine group is reacted with a compound comprising at least one spirobifluorene radical in a coupling reaction.

18. Use of a compound according to any one of claims 1 to 13, an oligomer, a polymer or a dendrimer according to claim 14 or a composition according to claim 15 as a hole blocking material, an electron injection material and / or an electron transport material in an electronic device.

19. An electronic device comprising at least one compound according to any one of claims 1 to 13, an oligomer, polymer or dendrimer according to claim 14, or a composition according to claim 15.

20. 20. The electronic device of claim 19, wherein the electronic device is selected from the group consisting of an organic electroluminescent device, an organic integrated circuit, an organic field effect transistor, an organic thin film transistor, an organic light emitting transistor, an organic solar cell, an organic photodetector, an organic photoreceptor, an organic field quenching device, a light emitting electrochemical cell, and an organic laser diode.

Citation Information

Patent Citations

  • JPP7073267B

  • Novel organic electroluminescent compounds and organic electroluminescent device using the same

    KR1020120044523A

  • Compound for organic optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode

    KR1020130077470A

  • Compound, organic optoelectric device and display device

    KR1020150125391A

  • Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof

    KR1020150135626A